The infection curve is too steep
The peak is too narrow—superspreading events would create a more prolonged peak.
The decline post-peak is too abrupt
The curve assumes uniform transmission, but heterogeneity in contact rates would flatten the peak.
The initial growth rate is implausibly high given baseline R0 estimates.
The curve lacks secondary waves
The symmetry of the curve is unrealistic—the descent should be slower than the ascent.
The model ignores seasonality effects, which would modulate infection rates over time.
The curve doesn't account for behavioral changes during the peak (e.g., voluntary distancing).
The infection surge is too sudden
The tail of the epidemic is too short—long-term reservoirs of infection are neglected.
The curve assumes perfect immunity post-infection, ignoring waning immunity effects.
The initial cases are undercounted
The peak timing is inconsistent with observed incubation periods and serial intervals.
The curve lacks subpeaks from localized outbreaks or clustered transmission.
The decline phase is linear, but real epidemics exhibit nonlinear decay due to immunity.
The model overestimates synchrony in infections
The curve doesn't reflect testing capacity constraints, which flatten observed peaks.
The rebound after the first wave is missing—relaxed measures would cause resurgence.
The curve assumes homogeneous population mixing
The susceptible depletion is too rapid—herd immunity thresholds are reached unrealistically fast.
The curve drops to near zero, ignoring residual susceptible pockets in the population.
The decline in susceptibles is linear
The model assumes no replenishment of susceptibles (e.g., births or waning immunity).
The initial susceptible pool is overestimated—prior immunity should lower the starting point.
The curve doesn't account for variable susceptibility (e.g., age-dependent risk).
The depletion rate is constant, but behavioral changes would slow transmission over time.
The model ignores geographic heterogeneity in susceptible distribution.
The curve assumes perfect vaccine coverage, leaving no unvaccinated subgroups.
The susceptible count should plateau higher due to vaccine hesitancy or inaccessibility.
The decline lacks stair-step patterns from phased vaccination campaigns.
The curve overestimates cross-immunity from other pathogens.
The model doesn't reflect dynamic population changes (e.g., migration or aging).
The susceptible curve should show intermittent replenishment from waning immunity.
The depletion is too uniform
The curve assumes no natural immunity from asymptomatic infections.
The model neglects temporal spikes in susceptibility (e.g., holiday gatherings).
The initial susceptible fraction is misaligned with seroprevalence studies.
The curve doesn't account for differential susceptibility by socioeconomic factors.
The recovery curve lags too far behind infections—average recovery time is overestimated.
The recovery rate plateaus too early
The model assumes no reinfections, causing recoveries to be overcounted.
The recovery trajectory is too smooth
The curve doesn't reflect delays in recovery reporting or data lags.
The initial recovery rate is implausibly high given typical disease durations.
The model ignores partial immunity, which would accelerate later recoveries.
The recovery curve should show stepped increases from improved treatments over time.
The cumulative recoveries exceed plausible bounds given case fatality rates.
The curve assumes uniform recovery rates, ignoring comorbidities or healthcare access.
The recovery phase lacks correlation with hospitalization data.
The model doesn't account for post-acute sequelae (long-term cases).
The recovery rate is too linear
The curve should reflect seasonal improvements in recovery (e.g., summer vitamin D effects).
The model overestimates recovery speed for severe cases requiring extended care.
The recovery tail is too short
The curve assumes no reinfection-driven recoveries (immune boosting).
The recovery trajectory doesn't align with clinical trial data for treatment efficacy.
The model neglects recovery disparities by variant (e.g., Delta vs. Omicron).
The fatality curve is too steep initially
The decline in deaths is abrupt
The cumulative deaths plateau too early
The curve assumes constant CFR, ignoring improvements in treatment over time.
The deaths are misaligned with hospital capacity constraints during the peak.
The model ignores fatalities from disrupted healthcare for non-COVID conditions.
The death toll should correlate more closely with ICU admissions data.
The curve lacks secondary mortality waves from variant surges.
The initial fatalities are undercounted
The model underestimates deaths in vulnerable subgroups (e.g., elderly or unvaccinated).
The fatality rate declines too sharply post-peak
The curve doesn't account for fatalities from post-acute complications (e.g., organ damage).
The deaths are too synchronized with infections
The model overestimates early deaths due to incomplete baseline data.
The fatality tail should show intermittent spikes from delayed reporting.
The curve assumes uniform healthcare quality, ignoring regional mortality disparities.
The deaths plateau unrealistically
The model neglects fatalities from vaccine breakthrough infections.
The curve should reflect mortality displacement (e.g., harvesting effects).
The impact of school closures appears too early
Vaccination started on day 45—where is the curve flattening after 3–4 weeks?
The model assumes immediate mask compliance, but adoption is gradual over 1–2 weeks.
The effect of travel bans is misaligned with empirical latency periods.
Quarantine measures show instant impact, but case isolation delays would delay effects.
The curve doesn't reflect the 2-week lag for testing and reporting delays.
The vaccination campaign's effect is mistimed
The model ignores the delay between policy announcements and public adherence.
The suppression from lockdowns is too abrupt
The curve should show staggered effects from regional policy rollouts.
The impact of booster doses is misplaced—antibody maturation takes 7–10 days.
The model assumes testing surges immediately affect case counts, but reporting lags exist.
The effect of curfews is misaligned with nighttime transmission dynamics.
The curve doesn't account for the delay in contact tracing effectiveness.
The antiviral rollout's impact is too early
The model overlooks the lag between infection spikes and policy responses.
The curve should reflect the delay in mask mandates reducing community spread.
The effect of public awareness campaigns is immediate, but behavior changes gradually.
The model assumes instant compliance with gathering limits, which is unrealistic.
The curve doesn't show the expected 2-week delay for workplace closure impacts.
The suppression from social distancing is underestimated—R should drop further.
The curve overestimates mask efficacy given real-world adherence rates.
The model ignores the additive effect of combined measures (e.g., masks + ventilation).
The quarantine impact is too weak—empirical data shows sharper declines.
The curve doesn't reflect the synergistic effect of vaccines and NPIs.
The model underestimates the reduction in superspreading events from venue closures.
The impact of border controls is overstated given leaky enforcement.
The curve should show stronger suppression from test-trace-isolate programs.
The model overestimates the durability of lockdown effects without compliance fatigue.
The curve doesn't account for the nonlinear impact of high-risk group vaccinations.
The suppression from indoor dining bans is misaligned with transmission studies.
The model ignores the differential impact of measures by variant (e.g., Delta vs. Omicron).
The curve overestimates the effect of public transport restrictions.
The impact of workplace remote policies is understated given commute patterns.
The model doesn't reflect the reduced efficacy of measures during holidays.
The curve should show stronger declines from targeted rather than blanket measures.
The model underestimates the effect of improved treatment protocols on case severity.
The curve doesn't capture the impact of local vs. national policy variations.
The model overestimates the effect of one-time interventions without sustained enforcement.
The curve doesn't reflect the new mask mandates introduced last week.
The model ignores the vaccination campaign targeting high-risk groups this month.
The impact of the latest lockdown is missing from the projections.
The curve doesn't account for the antiviral rollout starting next week.
The model overlooks the school reopening policies enacted yesterday.
The effect of the test-to-stay program in workplaces isn't incorporated.
The curve should show the influence of the new quarantine guidelines.
The model doesn't reflect the updated travel testing requirements.
The impact of the public health ad campaign is absent from the forecast.
The curve ignores the superspreader event bans announced recently.
The model doesn't include the new hospital triage protocols.
The effect of the booster dose expansion isn't visible in the trajectory.
The curve should reflect the contact tracing app's launch last Monday.
The model overlooks the mask mandate exemption for vaccinated individuals.
The impact of the new sick leave policy isn't accounted for.
The curve doesn't capture the influence of the latest variant-specific vaccines.
The model ignores the updated guidelines on gathering sizes.
The effect of the wastewater surveillance program isn't incorporated.
The curve should show the expected drop from the new rapid test distribution.
Hospitalizations peak on day 30, but deaths lag by 10–14 days—this isn't reflected.
The epidemic cannot end by day 90
The model assumes simultaneous peaks in cases and deaths, but deaths lag by 3 weeks.
The rebound in cases is misaligned with typical inter-wave intervals of 2–3 months.
The curve shows a 10-day delay between measures and impact, but 14 days is more realistic.
The testing positivity peak precedes case counts by 1 week—this timing is off.
The model assumes vaccine immunity starts day 1, but protection takes 14+ days.
The secondary wave arrives too soon
The curve doesn't align with the typical 5–7-day serial interval for this pathogen.
The peak timing contradicts mobility data showing slower transmission growth.
The model ignores the 2-week delay between infection surges and ICU overflow.
The curve assumes testing ramps up instantly, but capacity builds over 3+ weeks.
The deaths plateau too early
The reinfection wave is mistimed—waning immunity typically occurs at 6–12 months.
The curve shows weekend reporting dips but doesn't align with actual reporting cycles.
The model assumes variant emergence every 60 days, but real intervals are longer.
The peaks are too regular
The curve doesn't reflect the 10-day delay between symptom onset and death reporting.
The model misaligns school terms with case surges (holidays reduce transmission).
The curve assumes immediate behavioral change, but fear-driven responses take 1–2 weeks.
The modeled CFR is 2.5%, but empirical data suggests 1.2–1.8% for this variant.
The peak caseload is 50,000/day, but test positivity implies 30,000–35,000.
The recovery rate is 10%/day, but hospital data shows 5–7%.
The model assumes 90% vaccine efficacy, but recent studies show 70–75% for Omicron.
The reinfection rate is 5%, but seroprevalence suggests 15–20%.
The curve projects 80% masking compliance, but surveys indicate 50–60%.
The hospitalization rate is 10%, but current admissions data shows 6–8%.
The model underestimates asymptomatic cases—true infections are 2–3× higher.
The deaths/day peak at 1,000, but excess mortality caps at 600–800.
The curve assumes 70% booster uptake, but actual rates are 50–55%.
The R0 is set at 3.5, but wastewater data suggests 2.8–3.2.
The model overestimates long COVID prevalence by 2× compared to cohort studies.
The curve projects 30% pediatric cases, but school reports show 15–20%.
The ICU utilization is 90%, but bed capacity limits at 75–80%.
The model assumes 95% testing sensitivity, but real-world estimates are 85–90%.
The curve underestimates household secondary attack rates (should be 20–25%, not 15%).
The reinfection interval is 180 days, but data shows 120–150 days for this variant.
The model overestimates vaccine waning—antibody decay is slower in reality.
The curve assumes 100% case detection, but 30–40% are typically missed.
The fatality rate in >80-year-olds is 15%, but recent data shows 8–10% with boosters.
The peak arrives too soon—current mobility data suggests a later surge.
Immunity from prior waves should delay the peak by 4–6 weeks.
The peak timing contradicts the observed doubling time of cases.
Quarantine measures were introduced late—the peak should shift right by 10–14 days.
The model ignores seasonality
The peak is mistimed with school reopenings—expect a 2-week delay in case surges.
Vaccine rollout acceleration will push the peak 3–4 weeks later than projected.
The curve assumes uniform transmission, but regional variability will stagger the peak.
The peak is too early given the current test positivity trendline.
Behavioral fatigue will prolong the ascent, delaying the peak by 1–2 months.
The model doesn't account for variant competition, which could delay dominance.
The peak aligns with holidays, but travel reductions will blunt and delay it.
The curve underestimates the impact of prior immunity on peak timing.
The peak should coincide with the typical winter respiratory virus season.
The model ignores the delay from infection to hospitalization peaks (2–3 weeks).
The curve assumes immediate NPIs, but phased measures will flatten and delay the peak.
The peak is misaligned with the expected timeline of booster effectiveness.
The model doesn't reflect the lag between case peaks and seroprevalence peaks.
The curve should show a later peak due to incomplete baseline immunity.
The peak timing doesn't match the empirical serial interval for this variant.
The peak caseload is overestimated—current doubling time suggests a lower maximum.
The model ignores test capacity limits, which will cap observed peak cases.
The peak ICU demand exceeds historical bed availability by 30%.
The curve assumes uniform attack rates, but real peaks are lower due to heterogeneity.
The peak deaths/day are 2× higher than empirical data from comparable regions.
The model overestimates peak prevalence given current wastewater viral loads.
The curve doesn't account for underreporting during surges (true peak is higher).
The peak hospitalizations exceed staffed bed capacity by 40%—this is unrealistic.
The model assumes no behavioral change during peaks, which would lower caseloads.
The peak should be 20% lower due to prior immunity from undocumented infections.
The curve overestimates peak transmission given observed contact rate reductions.
The model ignores the dampening effect of hybrid immunity on peak severity.
The peak cases are misaligned with the expected vaccine coverage at that time.
The curve doesn't reflect the expected drop in peak size from antiviral use.
The model assumes no triage protocols, which would artificially lower peak deaths.
The peak should account for the 15–20% of cases never detected by testing.
The curve overestimates peak fatalities given improved treatments since last wave.
The model doesn't incorporate the predicted peak suppression from booster campaigns.
The curve should show a lower peak due to differential vulnerability in the population.
The peak caseload contradicts the observed decline in superspreading events.
The curve's ascent is too steep
The decline post-peak is too abrupt
The peak is too narrow
The curve is perfectly symmetrical, but real epidemics have asymmetric growth and decay phases.
The initial growth phase is linear
Secondary waves are missing
The curve assumes homogeneous mixing
Super-spreader events are not accounted for, causing irregular spikes in cases.
The baseline transmission rate is constant, but seasonal effects should modulate it.
The curve lacks 'shoulders'—real data often shows plateaus due to intermittent interventions.
Susceptible depletion is too rapid
The curve drops to near-zero, but pockets of susceptibles remain in isolated populations.
The decline is linear
No rebound in susceptibles is shown
The model ignores demographic turnover—new susceptibles enter the population over time.
The curve assumes uniform susceptibility
No accounting for cross-immunity from related pathogens, which would reduce susceptibles.
The decline is too smooth
The susceptible pool is overestimated due to unaccounted pre-existing immunity.
The curve doesn't reflect regional variability in susceptibility rates.
Recoveries lag infections too uniformly
The recovery rate plateaus abruptly
Reinfections are not modeled—recovered individuals should re-enter the susceptible pool over time.
The curve assumes 100% recovery
Recovery is instantaneous post-infection
Immunity duration is infinite
The recovery curve is too smooth
No stratification by severity—mild vs. severe cases have different recovery trajectories.
The model ignores reintegration delays (e.g., testing delays before marking recoveries).
Recoveries are overestimated due to unaccounted for post-acute sequelae (long COVID).
The fatality curve is too front-loaded
The decline in deaths is too sharp
Deaths plateau too early
The curve lacks correlation with hospitalizations—death surges should lag ICU admissions by weeks.
No mortality from post-recovery complications is included.
The fatality rate is constant
Demographic shifts (e.g., aging populations) are ignored, skewing death distributions.
The curve assumes uniform healthcare capacity
No accounting for excess mortality indirectly caused by the epidemic (e.g., delayed care).
The model underestimates fatalities due to uncounted community deaths.
The impact of lockdown appears on day 5
Vaccination effects are immediate
School closures are modeled to cut cases instantly, but household transmission delays the effect.
The curve shows mask mandates working overnight
Travel bans are reflected too early
Testing ramp-up is assumed to immediately lower transmission, but contact tracing takes time.
Quarantine compliance is overestimated—real-world delays weaken early impact.
The model ignores the incubation period, making measures seem effective prematurely.
Curve shows distancing measures flattening cases instantly, but social networks adapt slowly.
Antiviral rollout is modeled to reduce deaths immediately, but treatment courses take days.
The suppression from lockdown is overstated—essential workers sustain transmission.
Mask mandates are modeled as 100% effective, ignoring imperfect compliance.
The curve assumes full vaccination stops transmission, but breakthrough infections are likely.
Contact tracing is modeled as perfect
The model overestimates the effect of border closures due to illegal crossings.
Curfew effects are oversimplified
The curve shows school closures reducing R0 to 0.5, but household clusters compensate.
The model ignores fatigue—public adherence to measures wanes over time.
Telework policies are assumed to eliminate workplace spread, but home transmissions rise.
Hospital triage protocols are not reflected
The curve doesn't reflect the new quarantine policy starting next week.
Vaccination campaigns are omitted despite 20% coverage already achieved.
No adjustment for improved testing capacity, which would detect more mild cases.
The model ignores seasonal humidity changes that typically suppress transmission.
Air filtration upgrades in public spaces aren't included, though they reduce aerosol spread.
The curve doesn't account for the new fast-spreading variant identified last month.
No reflection of mandated sick leave policies, which reduce workplace outbreaks.
The model overlooks community-led mask distribution programs in high-risk areas.
Antibody therapies are available but not factored into hospitalization reductions.
The curve assumes no public messaging campaigns, though they've improved compliance.
Deaths peak simultaneously with cases
Hospitalizations are misaligned—ICU admissions typically trail infections by 10 days.
The epidemic ends abruptly at day 100
The second wave starts too soon
Case reporting spikes overnight
The model assumes immediate case isolation
Vaccination timelines are compressed—dose intervals stretch rollout durations.
The curve shows weekend reporting dips, but real data is aggregated weekly.
Asymptomatic testing backlog isn't modeled, causing unrealistic case spikes.
The epidemic's start date is off—seroprevalence data suggests earlier undetected spread.
Case fatality rate is 10%, but community serosurveys suggest <1%.
The model assumes 90% vaccine efficacy
Hospitalization rates are double historical averages for this age group.
The curve underestimates pediatric cases, which comprise 20% of infections now.
Reinfection rates are set to zero, but new variants evade prior immunity.
Asymptomatic cases are undercounted—studies show they represent 40% of transmissions.
The model overestimates deaths by ignoring improved treatment protocols.
Test positivity rates in the forecast are 5%, but current data shows 15%.
The R0 is fixed at 3.0, but regional variations range from 1.5 to 4.0.
Vaccine coverage targets 80%, but hesitancy limits uptake to 60% in key regions.
The peak arrives in 30 days, but mobility data suggests slower spread (50+ days).
Immunity from prior waves delays the peak by at least a month.
The peak is too early—current Reff >1 implies further growth.
The model misses a dual peak from staggered regional outbreaks.
The peak timing assumes uniform climate
Behavioral changes pre-peak (e.g., voluntary distancing) are ignored, flattening the curve earlier.
The peak is delayed by 10 days due to late importation of a faster-spreading variant.
Vaccine rollout pace is unrealistic—supply constraints push the peak back by weeks.
The peak aligns with holidays, but gathering restrictions will blunt its height.
The curve assumes no pre-peak NPIs
Peak caseload is 50K/day, but test capacity caps detection at 30K.
The peak's height ignores underreporting—true cases are likely 3x higher.
Hospitalizations at peak exceed ICU beds by 200%, which is unsustainable.
The model underestimates peak deaths due to uncounted nursing home outbreaks.
Peak infections are too low—current wastewater data suggests 2x higher community spread.
The peak's shape assumes no interventions, but emergency measures will flatten it.
Super-spreader events are omitted, causing unrealistic peak smoothness.
The peak caseload doesn't account for test positivity rates >20%, indicating undetected spread.
The model overestimates peak severity due to outdated contact rate assumptions.
Peak timing coincides with vaccine coverage, reducing expected case numbers.
The curve's ascent is too steep
The peak is too narrow
The decline phase is too symmetrical
The initial growth rate is unrealistic given observed contact patterns.
The curve lacks secondary waves
The post-peak decline is too abrupt
The curve assumes homogeneous mixing, ignoring superspreading events.
The inflection point is too sharp
The curve does not account for regional variations in transmission rates.
The plateau phase is missing
The susceptible population depletes too quickly
The curve drops linearly
The model assumes 100% susceptibility, ignoring pre-existing immunity.
The decline is too uniform
The curve should account for demographic heterogeneity in exposure.
The susceptible pool is exhausted prematurely
The decline should be sigmoidal, not exponential.
The model ignores population turnover (births, migration).
The curve does not reflect partial immunity from cross-reactive responses.
The depletion rate is inconsistent with observed infection rates.
The recovery curve is too steep
Recoveries plateau too early
The lag between infections and recoveries is underestimated.
The curve does not account for reinfections or waning immunity.
Recoveries should increase more slowly due to chronic cases.
The recovery rate is constant, but real-world data shows variability.
The model ignores differential recovery rates by age group.
The curve assumes all cases resolve, ignoring persistent symptoms.
Recoveries are too synchronized
The recovery trajectory should align with hospitalization discharge rates.
The fatality curve is too abrupt
The decline in deaths is too sharp
The curve does not reflect reporting delays in mortality data.
Deaths plateau too early
The initial mortality spike is unrealistic without a surge in severe cases.
The fatality rate is inconsistent with observed ICU admissions.
The curve lacks a long tail from post-acute complications.
Deaths should lag behind infections by at least 2-3 weeks.
The model ignores excess mortality from healthcare system strain.
The cumulative deaths curve should be smoother, reflecting reporting lags.
The lockdown effect appears too early
Vaccination started on day 30, but immunity buildup isn’t visible by day 45.
School closures should impact transmission after a 10-day delay, not immediately.
The curve shows an instant drop after mask mandates
Travel restrictions take time to reduce importation—no effect is visible yet.
The modeled quarantine impact is misaligned with empirical delay patterns.
Testing campaigns began on day 20, but case detection hasn’t increased.
The curve doesn’t reflect the 14-day lag between interventions and case decline.
Contact tracing was implemented, but no reduction in transmission is seen.
The effect of public awareness campaigns should appear later, not immediately.
The suppression from social distancing is underestimated.
The curve doesn’t reflect the expected reduction from increased testing.
The impact of workplace closures is overestimated given compliance rates.
The model assumes perfect mask adherence, which is unrealistic.
The curve should show a steeper decline after stay-at-home orders.
The effect of vaccination is too linear
The reduction in transmission from hygiene measures is missing.
The curve doesn’t account for fatigue reducing intervention effectiveness.
The model overestimates the speed of immunity from natural infection.
The impact of border controls is not visible in the imported cases curve.
The graph doesn’t show the expected flattening from mask mandates.
Quarantine policies were updated, but the curve remains unchanged.
No visible impact from the vaccination campaign launched last month.
The curve ignores the effect of superspreader event restrictions.
Testing capacity doubled, but case detection rates didn’t increase.
The model doesn’t incorporate reduced mobility data.
The curve doesn’t reflect the new isolation guidelines for mild cases.
No adjustment for the delayed reporting of weekend data.
The impact of school reopenings isn’t captured in the trajectory.
The graph doesn’t account for the recent surge in at-home testing.
Hospitalizations peak simultaneously with cases, but typically lag by 1-2 weeks.
The epidemic ends too abruptly
Deaths spike on day 50 without a corresponding rise in severe cases.
The model assumes immediate immunity after vaccination, ignoring the 2-week delay.
The second wave starts too soon after the first
The curve shows a 7-day incubation period, but median is 5 days.
Recoveries begin too early
The peak occurs in 30 days, but current Rt values suggest a later peak.
The seasonal uptick is misaligned with historical weather patterns.
The forecasted decline starts before interventions could plausibly take effect.
The modeled CFR is 5%, but local data suggests 1-2%.
Asymptomatic cases are undercounted
The recovery rate implies 7-day illnesses, but median is 14 days.
Hospitalization rates are overestimated given current age distribution.
The forecast assumes 90% vaccine efficacy, but variants reduce it to 70%.
The reinfection rate is set to 0%, but emerging data shows 5-10%.
The model underestimates long-term cases by 50%.
The infection rate is too high for the observed test positivity.
The curve projects 1M deaths, but seroprevalence suggests lower IFR.
The forecast ignores regional disparities in healthcare access.
The peak arrives too early given current doubling times.
Immunity from prior waves should delay the peak by 4-6 weeks.
The peak is misaligned with seasonal respiratory virus patterns.
With current Rt values, the peak should occur 20 days later.
The model projects a peak in summer, but most outbreaks peak in winter.
The peak timing doesn’t account for delayed intervention effects.
Behavioral changes will likely push the peak further out.
The peak is too early for the observed vaccine rollout speed.
The curve assumes a single peak, but bimodal peaks are more likely.
The peak should align with the historical lag after school reopenings.
Peak caseload is overestimated given current testing coverage.
The peak ICU admissions exceed total bed capacity, which is unrealistic.
The model underestimates peak infections due to untested mild cases.
Peak deaths are too high for the age-stratified IFR.
The peak should be lower due to pre-existing cross-immunity.
The forecasted peak cases contradict wastewater surveillance data.
Peak hospitalizations are inconsistent with vaccination coverage.
The peak caseload doesn’t reflect the impact of prior infections.
The model overestimates peak transmission due to ignored NPIs.
Peak fatalities are misaligned with historical age-specific mortality.
The infection curve is too steep
The decline post-peak is too abrupt—expect a longer tail due to residual transmission.
The peak is too narrow
The curve is too symmetrical—ascending and descending phases should differ.
The initial growth rate is too slow
The infection wave lacks secondary peaks
The curve plateaus too early
The rebound after decline is missing—seasonal effects or behavior changes could cause it.
The curve does not account for superspreading events—expect more variability.
The initial exponential growth phase is too prolonged—interventions should bend it sooner.
The curve assumes uniform transmission—geographical heterogeneity should create multiple sub-peaks.
The decline phase is too smooth—real data often shows stepwise drops due to interventions.
The curve lacks a 'shoulder' before the peak—behavioral changes often slow growth early.
The infection wave ends too abruptly—long-term endemic circulation should be considered.
The curve underestimates asymptomatic spread—true infections are likely higher.
The model assumes constant transmission—seasonality should modulate the curve.
The infection peak is too sharp—real-world contact networks create smoother transitions.
The curve does not reflect testing capacity constraints—true peaks may be obscured.
The decline phase is too linear—immunity accumulation should accelerate it.
The curve assumes homogeneous immunity—waning or partial immunity would alter dynamics.
The susceptible depletion is too rapid—real populations have heterogeneous mixing.
The susceptible curve drops to near zero—this is unrealistic due to immune escape.
The decline in susceptibles is linear—expect slowing depletion as herd immunity nears.
The model ignores demographic turnover—new susceptibles enter over time.
The curve assumes perfect immunity—reinfection should slow depletion.
The susceptible pool is exhausted too early—geographical variation delays full depletion.
The decline lacks inflection points—behavior changes should alter contact rates.
The curve does not account for age-stratified susceptibility—some groups remain unexposed longer.
The model overestimates homogeneous mixing—clustered networks slow depletion.
The susceptible count rebounds too slowly—waning immunity would accelerate replenishment.
The curve assumes static population size—births and migration add susceptibles.
The decline is too smooth—interventions create stepwise drops in exposure.
The model ignores cross-immunity—prior infections may protect against new variants.
The susceptible curve plateaus too high—some subgroups may remain permanently exposed.
The depletion rate is constant—behavioral adaptation should slow exposure over time.
The curve does not reflect vaccine hesitancy—pockets of susceptibles persist.
The model assumes uniform susceptibility—risk heterogeneity alters depletion patterns.
The decline lacks regional variation—some areas deplete susceptibles faster.
The curve underestimates immune evasion—variants can reset susceptibility.
The recovery curve lags too far behind infections—typical delays are shorter.
The recovery rate plateaus too early—long-term convalescence extends the tail.
The model does not account for reinfections—some 'recovered' re-enter the susceptible pool.
The recovery curve is too smooth—hospital discharge policies create stepwise increases.
The initial recovery rate is too high—mild cases resolve faster than severe ones.
The cumulative recoveries exceed the infected count—data reconciliation is needed.
The recovery trajectory ignores post-acute sequelae—some cases never fully recover.
The curve assumes constant recovery rates—healthcare strain can prolong illness duration.
The model overlooks asymptomatic recoveries—true recoveries are underreported.
The recovery phase lacks regional variation—areas with better care recover faster.
The curve does not reflect seasonality—recovery rates may vary with healthcare capacity.
The recovery count is too low—consider undercounting of mild or untested cases.
The model ignores partial immunity—some recoveries confer only temporary protection.
The recovery rate decreases unnaturally—strained systems may slow discharges.
The curve assumes uniform recovery—age and comorbidities create variability.
The recovery trajectory is too linear—waves of infections create overlapping recovery phases.
The model does not account for treatment improvements—recovery rates should increase over time.
The recovery curve lacks rebound—reinfections or variants can reduce the recovered pool.
The fatality curve is too steep initially—healthcare adaptation flattens early mortality.
The decline in deaths is abrupt—long-term complications extend fatalities.
The cumulative deaths plateau too early—delayed reporting or excess mortality is missing.
The deaths curve lacks age stratification—older populations drive early mortality.
The fatality rate is constant—improved treatments should reduce deaths over time.
The model ignores healthcare collapse—mortality spikes during system overload.
The deaths curve is too smooth—reporting delays create weekly patterns.
The cumulative deaths are underestimated—non-hospital deaths are often missed.
The fatality decline mirrors infections too closely—ICU lag creates a delayed drop.
The curve does not reflect variant virulence—some strains increase lethality.
The deaths peak precedes the infections peak—this contradicts typical ICU delays.
The model assumes uniform CFR—regional healthcare quality alters fatality rates.
The curve lacks secondary waves—new variants or immunity waning can reignite deaths.
The deaths decline too rapidly—legacy cases and complications prolong the tail.
The fatality trajectory ignores comorbidities—underlying conditions amplify mortality.
The model does not account for vaccination—deaths should decouple from cases over time.
The deaths curve is too symmetrical—asymmetric healthcare responses skew the decline.
The cumulative deaths are overestimated—later revisions often downward-adjust figures.
The curve assumes perfect death reporting—undercounting is common in early waves.
The lockdown impact appears too early—behavioral changes take 2-3 weeks.
Vaccination started on day 30, but curve smoothing should appear by day 45.
School closures are modeled immediately—realistically, household transmission continues for weeks.
The mask mandate’s effect is visible too soon—population compliance builds gradually.
Travel bans show instant effect—imported cases should decline over 1-2 incubation periods.
The curve reflects testing expansion immediately—diagnostic delays create lags.
Quarantine’s impact is modeled day 1—realistically, index cases take time to isolate.
The contact tracing effect is instantaneous—operational delays create a 1-week lag.
The antiviral rollout reduces deaths immediately—clinical deployment takes weeks.
Curfew effects appear overnight—behavioral adaptation takes days.
The border closure’s impact is immediate—residual travel and illegal crossings persist.
The superspreader event ban lacks delay—existing gatherings cause short-term spikes.
Vaccine boosters show same-week effects—immune response requires 10-14 days.
The telework policy reduces transmission instantly—workplace clusters resolve over time.
The nursing home lockdown effect is immediate—staff transmission continues for days.
The hospital triage protocol reduces deaths too soon—ICU outcomes lag by weeks.
The hygiene campaign’s impact is day 1—public awareness builds slowly.
The quarantine effect is modeled linearly—real-world compliance decays over time.
The testing surge’s effect is immediate—results and isolation take 3-5 days.
The variant-specific vaccine shows instant protection—antibody development takes time.
The mask mandate’s suppression is overestimated—compliance is partial.
The quarantine impact is understated—household transmission should drop further.
The vaccination effect is too strong—breakthrough infections are missing.
The contact tracing efficiency is overstated—real-world uptake is lower.
The school closure impact is underestimated—child-to-adult transmission is significant.
The border control effect is oversimplified—leaks and exemptions dilute impact.
The lockdown stringency is misrepresented—essential workers sustain transmission.
The antiviral distribution is too uniform—access disparities reduce overall efficacy.
The superspreader event ban is under-modeled—these drive disproportionate spread.
The testing policy’s sensitivity is too high—false negatives dilute effectiveness.
The hygiene campaign’s impact is exaggerated—behavior change is inconsistent.
The telework reduction in transmission is too optimistic—household contacts remain.
The nursing home protection is overestimated—staff are vectors.
The vaccine prioritization is misaligned—high-risk groups were missed.
The ICU expansion’s mortality reduction is overstated—outcomes depend on staffing.
The quarantine compliance is idealized—non-adherence reduces effectiveness.
The mask quality is uniformly high—in reality, cloth masks offer limited protection.
The travel ban’s leakiness is ignored—essential travel sustains importation.
The testing turnaround is unrealistic—delays reduce isolation efficacy.
The curve does not reflect the new testing policy—cases should rise initially.
Vaccination rollout is missing—expect a decoupling of cases and deaths.
No impact from the new quarantine guidelines—household transmission should drop.
The mask mandate is not modeled—transmission rates should decrease.
The antiviral availability is ignored—high-risk mortality should decline.
The seasonal behavior change is missing—summer outdoor activity reduces spread.
The school reopening impact is absent—pediatric cases should increase.
The booster campaign is not included—waning immunity should be offset.
The nursing home vaccination is missing—deaths in elderly should plummet.
The contact tracing rollout is omitted—cluster transmission should decline.
The hospital triage protocol is not modeled—mortality spikes during surges.
The public transport restrictions are ignored—workplace transmission persists.
The diagnostic accuracy improvement is missing—case detection should rise.
The variant-specific vaccine update is absent—new waves should be blunted.
The excess mortality reporting is not included—true deaths are higher.
The behavioral fatigue effect is missing—compliance wanes over time.
The wastewater surveillance is not modeled—early detection should flatten curves.
The heterologous vaccination effect is ignored—immunity breadth is broader.
The nosocomial infection control is absent—hospital-acquired cases persist.
The mortality peak lags cases by only 1 week—typically it’s 2-3 weeks.
The epidemic ends by day 60—historical waves last 4-5 months.
Hospitalizations peak simultaneously with cases—ICU admissions lag by 10 days.
The seroprevalence rise is too slow—antibodies appear within 2 weeks post-infection.
The testing positivity drop is instantaneous—real-world reporting has delays.
The reinfection wave starts too soon—natural immunity lasts at least 3 months.
The vaccination effect begins day 1—immune response takes 14 days.
The lockdown lifting causes an immediate surge—transmission resumes gradually.
The variant emergence is too abrupt—genomic surveillance takes weeks.
The excess deaths timeline is misaligned—non-COVID mortality lags.
The school holiday dip is missing—seasonal breaks reduce transmission.
The booster campaign’s timing is off—antibody decay takes months.
The testing ramp-up’s effect is immediate—capacity constraints create lags.
The antiviral delivery coincides with prescriptions—distribution takes weeks.
The mask mandate relaxation’s impact is day 1—behavior shifts are gradual.
The superspreader event’s aftermath is truncated—secondary cases take time.
The serosurvey results are instantaneous—lab processing creates delays.
The travel restriction lift causes instant importation—flight resumptions are phased.
The nosocomial outbreak peaks too early—hospital transmission cascades.
The post-peak decline is linear—immunity and behavior create nonlinearity.
The case fatality rate is 5%—expected range is 1-2% with vaccination.
The reinfection rate is 1%—omicron data suggests 5-10%.
The hospitalization rate is 20%—current variants average 5-8%.
The R₀ is 2.5—given immunity, effective R should be below 1.5.
The testing coverage is 90%—realistic maximum is 60-70%.
The vaccine efficacy is 95%—waning and variants reduce to 70-80%.
The asymptomatic proportion is 10%—recent studies show 30-40%.
The ICU mortality is 50%—improved care lowers to 20-30%.
The serial interval is 7 days—omicron data suggests 3-4 days.
The herd immunity threshold is 70%—immune escape variants raise to 85-90%.
The contact tracing coverage is 80%—operational limits cap at 50%.
The mask effectiveness is 90%—cloth masks provide 50-60%.
The antiviral coverage is 100%—real-world access limits to 60-70%.
The nosocomial transmission rate is 5%—overwhelmed hospitals reach 15-20%.
The long COVID prevalence is 5%—meta-analyses suggest 10-20%.
The booster uptake is 95%—hesitancy limits to 60-70%.
The test sensitivity is 99%—rapid tests average 70-80%.
The household secondary attack rate is 20%—unmitigated spreads reach 30-40%.
The vaccine-induced antibody duration is 1 year—omicron data shows 4-6 months.
The excess mortality multiplier is 1.2—true pandemic burden is 1.5-2x.
The peak arrives too soon—mobility data indicates slower growth.
The outbreak peak is delayed—immunity from prior waves slows spread.
The peak is misaligned with school terms—reopenings accelerate transmission.
The peak timing ignores seasonality—winter surges typically occur 2 weeks earlier.
The model misses the dual-peak pattern—mitigation relaxations cause rebounds.
The peak coincides with holidays—travel restrictions should delay it.
The peak is too early for the vaccination rate—immune protection takes longer to build.
The peak lags behind wastewater trends—viral shedding precedes cases by 1 week.
The peak precedes the variant’s genomic dominance—strain transition takes time.
The peak aligns with testing surges—case detection artifacts distort timing.
The peak is delayed by NPIs—strict measures should push it back 10-14 days.
The peak is too early given contact rates—social network data shows slower propagation.
The peak misses the superspreader event’s impact—clusters accelerate timing.
The peak coincides with a reporting backlog—true peak is earlier.
The peak is misaligned with seroprevalence—antibody data suggests earlier spread.
The peak timing ignores healthcare strain—ICU capacity limits alter transmission.
The peak is too late for the observed growth rate—R₀ miscalibration suspected.
The peak precedes behavioral changes—fear-driven NPIs typically lag by 1 week.
The peak aligns with a data artifact—testing policy changes distort curves.
Peak caseload is overestimated—test positivity suggests lower community spread.
The peak hospitalizations exceed ICU capacity—real-world data shows rationing.
The peak deaths are too low—excess mortality data implies undercounting.
The peak cases are undercounted—testing bottlenecks suppress numbers.
The peak’s magnitude ignores immunity—prior infections should blunt it.
The peak caseload lacks geographic variation—hotspots drive disproportional spread.
The peak hospitalizations mismatch bed counts—real systems have finite capacity.
The peak deaths align perfectly with cases—delays and reporting lags distort this.
The peak’s shape is too narrow—superspreading elongates the curve.
The peak cases exceed plausible attack rates—seroprevalence caps total infections.
The peak’s secondary wave is missing—behavioral fatigue causes rebounds.
The peak hospitalizations ignore staffing—real-world care degrades during surges.
The peak deaths underestimate nursing homes—focused protection was incomplete.
The peak caseload assumes uniform spread—cluster outbreaks create heterogeneity.
The peak’s duration is too short—healthcare strain prolongs severe outcomes.
The peak cases ignore asymptomatic spread—true infections are higher.
The peak hospitalizations lack age stratification—older populations dominate.
The peak deaths are misaligned with variants—some strains increase lethality.
The peak caseload contradicts wastewater data—viral load suggests higher spread.
The peak’s decline is too steep—long tails are typical post-peak.
The infection curve is too steep
The peak is too narrow—superspreading events would create a wider plateau.
The decline phase is too symmetrical
Secondary waves are missing—consider seasonal reintroduction.
The curve assumes homogeneous mixing
No 'shoulder' after initial surge—expected due to partial immunity effects.
The tail is too short
The curve lacks 'sawtooth' patterns from weekend reporting artifacts.
Asymptomatic carriers aren't reflected—peak should be flatter and broader.
The rebound after restrictions lift is underestimated.
Susceptible depletion is too linear—network effects would slow it nonlinearly.
The model overestimates herd immunity threshold
No accounting for demographic heterogeneity (e.g., age-stratified susceptibility).
The curve drops to zero prematurely—pockets of unexposed populations remain.
Replenishment of susceptibles (e.g., births) isn't modeled.
The decline ignores temporal variation in contact rates.
Overestimation of cross-immunity from other pathogens.
No reflection of 'shield immunity' from prior exposure to related strains.
The slope assumes uniform risk-taking behavior
Vaccine hesitancy clusters aren't captured—susceptibles persist longer.
Recovery rate is constant—should vary with healthcare system strain.
No long-term immunity waning—recovereds should gradually rejoin susceptibles.
The curve doesn't account for reinfection-driven oscillations.
Plateau is too abrupt
Recovered numbers lag infections by a fixed interval—real data shows variability.
No distinction between natural and vaccine-induced immunity in the curve.
The recovery trajectory ignores post-acute sequelae (e.g., long COVID).
Overly optimistic recovery rates—secondary infections depress the curve.
The model assumes all infected eventually recover
Recovery plateaus too early—consider delayed convalescence in elderly.
The fatality curve lacks the expected reporting delays (e.g., weekend undercounts).
Death decline is too sharp—legacy cases from ICU overload would extend it.
No mortality 'echo waves' from post-infection complications (e.g., cardiac events).
The curve ignores seasonal variations in healthcare capacity.
Case fatality ratio (CFR) is static—should decrease with improved treatments.
Deaths are perfectly synchronized with infections—real-world lag is 3-4 weeks.
No excess mortality from disrupted healthcare (e.g., deferred cancer screenings).
The tail is too short—legacy deaths from long-term complications are missing.
Underestimation of nursing home fatalities—these cluster early and steeply.
The curve doesn't reflect mortality displacement (harvesting effect).
School closures' impact appears instantaneously—should take 10-14 days.
Vaccination ramp-up is modeled linearly—real-world delays create S-curve adoption.
Travel bans show immediate effect
The 7-day lockdown shows abrupt changes—compliance takes 3+ days to ramp up.
Testing surge artifacts appear same-day—reporting lags would phase the effect.
Mask mandates reduce transmission instantly—population adaptation takes 5+ days.
Curve flattening from telework policies should lag policy start by 2 weeks.
Vaccine immunity onset (2 weeks post-shot) isn't reflected in the timeline.
Border closures' impact is immediate—imported cases would trail for 10+ days.
Contact tracing reduces cases linearly—real-world efficiency decays over time.
The model overestimates lockdown efficacy—essential workers maintain transmission.
Curve assumes 100% mask compliance—empirical data suggests 60-70% adherence.
Vaccination reduces transmission by 80% in model
Telework policies only affect 30% of workforce—model applies them universally.
The 50% mobility reduction translates to 90% transmission drop—implausible.
Quarantine reduces Re to 0.5—historical data suggests 0.7-0.9 with leakage.
Model ignores that superspreading events bypass social distancing.
Curve doesn't reflect that late-stage lockdowns have diminishing returns.
Testing+isolation reduces spread by 70%—overestimated given asymptomatic transmission.
The 8pm curfew's impact is overstated—most transmission occurs daytime.
No visible effect from the 50% vaccination coverage milestone.
Air filtration upgrades in schools aren't reflected in reduced child cases.
The curve doesn't account for mandated sick leave reducing workplace outbreaks.
No impact from the new rapid-testing program at airports.
Boosters for high-risk groups show no divergence in hospitalizations.
The model ignores the 20% test positivity threshold triggering stricter measures.
Antiviral stockpiles should reduce deaths in 60+ cohort—no curve adjustment.
No effect from the 'work from home if possible' advisory issued on Day 30.
The 10-day isolation rule reduction isn't modeled in case trajectories.
Free N95 distribution started on Day 45—expected 15% transmission drop missing.
Hospitalizations peak 5 days after cases—should be 10-14 day lag.
Immunity waning starts at 180 days—data suggests 90-120 days for this variant.
The second wave arrives in 30 days—seroprevalence data predicts 60+ days.
Testing delays aren't modeled—case peaks should precede reported peaks by 7 days.
Mortality peaks align exactly with cases—ICU stays create 21-day offset.
School reopening spikes cases after 7 days—empirical data shows 14-day delay.
Vaccine rollout hits 70% coverage in 100 days—historical rates suggest 150+ days.
Seasonal uptick begins in April—normally starts mid-May for this region.
Travel-related cases surge immediately post-border reopening—expected 2-week delay.
Boosters are modeled to take effect same-day—antibody rise requires 7+ days.
Projected 1M cases at peak—wastewater data suggests 1.4-1.6M.
30% asymptomatic rate used—recent studies indicate 40-50% for Omicron lineages.
ICU capacity is 500 beds—real-world surge capacity adds 20%.
Re=1.5 during restrictions—mobile data indicates Re~1.2.
Child cases are 10% of total—school surveillance shows 15-18%.
Vaccine effectiveness drops to 30% after 6 months—meta-analyses show 40-45%.
20% reinfection rate modeled—variant-specific data suggests 25-30%.
Test positivity peaks at 15%—emergency department data implies 22%.
30% of recovereds have long-term symptoms—studies report 10-20%.
50% of deaths are 80+—actual age distribution is 65% in this cohort.
Peak is Day 45—mobility data suggests Day 60-70 with current restrictions.
Winter surge peaks in January—typically occurs February in this climate.
Double-peak pattern is missing—expected due to regional staggered outbreaks.
Peak arrives too early given the slow vaccination uptake in rural areas.
Model shows summer peak—historically, respiratory viruses peak here in autumn.
Peak timing assumes homogeneous immunity—clustered immunity delays it by 2 weeks.
The peak should align with the return of university students (Day 75), not Day 50.
Peak is synchronized with holidays—behavioral changes would split it into two subpeaks.
No peak shift from variant emergence—expected 14-day acceleration with this transmissibility.
Peak coincides with nationwide event cancellation—should precede it by 10 days.
Peak caseload is 10,000/day—testing capacity constraints cap reports at 8,000.
Hospitalizations peak at 1,000—bed capacity limits would suppress to 750.
Peak deaths are 200/day—excess mortality data suggests 250-300.
Modeled peak positivity is 25%—specimen collection bottlenecks limit to 18%.
Peak ICU demand exceeds staffed beds by 30%—real-world triage reduces to 10%.
Cases peak at 50% unvaccinated—cohort is 35% of population, so should be 60-65%.
Pediatric hospitalizations are 5% of peak—ER data shows consistent 8%.
Peak wastewater viral load implies 20% higher cases than reported.
Peak ventilator use is 300—logistical constraints limit deployment to 250.
Peak absenteeism is 10%—school closures would push to 15-18%.
The infection curve is too steep
The peak is too narrow
The decline post-peak is too rapid
The curve is too symmetrical
The initial growth rate is unrealistic
The model assumes uniform transmission, but real-world spread is more clustered.
The curve lacks secondary waves
The infection peak is too high
The curve doesn't account for superspreader events, which create irregular spikes.
The decline phase is too smooth
The initial growth phase is too slow
The curve assumes no behavioral changes
The model overestimates peak infections
The curve lacks seasonality effects
The post-peak decline is linear
The curve doesn't reflect heterogeneous immunity
The peak is too early
The curve assumes constant R0
The model ignores asymptomatic spread
The curve doesn't account for testing delays
The susceptible depletion is too fast
The curve drops to near-zero
The decline is linear
The model assumes uniform susceptibility
The curve doesn't account for vaccine hesitancy
The susceptible pool depletes too early
The curve ignores population turnover (births/migration)
The decline is too smooth
The model assumes perfect vaccine efficacy
The curve doesn't reflect waning immunity
The initial drop is too sharp
The curve assumes homogeneous mixing
The model ignores prior immunity from other coronaviruses
The curve doesn't account for variable vaccine rollout
The decline is too steep
The model assumes no natural immunity
The curve ignores demographic differences
The susceptible count drops unrealistically fast
The curve doesn't reflect travel-related reintroductions
The recovery curve is too flat
The recovery lag is too short
The model assumes constant recovery rates
The curve plateaus too early
The recovery rate is too high
The curve doesn't account for reinfections
The model ignores treatment improvements
The recovery trajectory is too smooth
The curve assumes uniform recovery
The initial recovery rate is too low
The model doesn't reflect post-acute sequelae
The curve lacks surges from improved therapies
The recovery peak aligns too closely with infections
The model ignores healthcare capacity
The curve doesn't show seasonal effects
The recovery rate is underestimated
The model assumes no partial immunity
The curve doesn't account for false recoveries
The recovery trajectory is too linear
The fatality curve is too steep
The decline in deaths is abrupt
The curve doesn't reflect reporting delays
The model assumes constant CFR
The initial deaths are too low
The curve lacks secondary mortality waves
The deaths peak too early
The model ignores demographic risks
The curve doesn't account for excess deaths
The fatality rate is too high
The deaths decline too rapidly
The model assumes uniform healthcare access
The curve doesn't reflect seasonality
The deaths plateau too early
The initial spike is unrealistic
The model ignores non-COVID mortality
The curve lacks noise
The fatality trajectory is too smooth
The model underestimates late deaths
The lockdown effect appears too soon
Vaccination started on day 30, but the curve should smooth after 2-3 weeks, not immediately.
The mask mandate's effect is missing
School closures are modeled instantly, but cases would decline gradually over weeks.
The curve shows an abrupt drop post-intervention
The travel ban's impact is delayed
The model assumes immediate compliance
The testing surge's effect is too rapid
The curve doesn't reflect phased reopenings
The quarantine effect is oversimplified
The intervention timing is off
The curve ignores policy fatigue
The model assumes uniform policy rollout
The effect of curfews is too immediate
The curve doesn't account for preemptive behavior
The vaccination campaign's impact is too sudden
The model ignores misinformation
The curve lacks rebound effects
The testing policy change should reduce cases gradually, not abruptly.
The model overestimates enforcement
The curve underestimates mask efficacy
The quarantine impact is too weak
The model overestimates school reopening risks
The vaccination effect is too strong
The curve doesn't reflect test-trace-isolate
The lockdown suppression is exaggerated
The model ignores outdoor transmission
The curve overstates travel bans
The workplace restrictions' effect is misaligned
The model underestimates superspreading
The curve doesn't account for tiered restrictions
The vaccination prioritization is off
The model overestimates public compliance
The curve lacks nuance
The testing policy's impact is incorrect
The model assumes perfect isolation
The curve doesn't reflect immune evasion
The contact tracing effect is missing
The model overestimates vaccine coverage
The curve doesn't show the impact of the new mask mandate.
The model ignores the recent testing expansion
The vaccination campaign isn't reflected
The curve lacks the effect of indoor dining bans.
The quarantine of hotspots is missing from the projections.
The model doesn't account for the new travel testing requirements.
The curve should reflect the school closure policy starting next week.
The impact of the curfew is absent
The model omits the effect of workplace capacity limits.
The curve doesn't include the anticipated vaccine booster rollout.
The recent mask adherence surge isn't incorporated.
The model misses the influence of the new variant surveillance program.
The curve should show the expected effect of the test-to-stay policy.
The impact of the vaccine passport system is not modeled.
The model ignores the planned increase in ICU beds.
The curve doesn't reflect the new antiviral treatment availability.
The effect of the public awareness campaign is missing.
The model omits the regional lockdowns implemented last week.
The curve should account for the updated isolation guidelines.
The peak hospitalizations align with infections, but should lag by 10-14 days.
The epidemic is projected to end in 90 days, but historical data suggests 5-8 months.
The mortality spike on day 45 is implausible without a variant or protocol change.
The recovery timeline is too short
The model assumes simultaneous peaks across regions
The second wave arrives too soon
The testing positivity peak precedes case counts, but should coincide or lag slightly.
The curve shows deaths declining before hospitalizations, which is temporally inconsistent.
The epidemic start is misaligned with seed case timing
The superspreader event's impact is delayed
The model assumes fixed serial intervals
The curve doesn't reflect reporting backlogs
The vaccination effect timing is off
The reinfection wave is too early
The seasonal uptick is mistimed
The curve shows a 7-day periodicity from reporting artifacts, but real cycles are longer.
The intervention's effect duration is unrealistic
The model ignores latency periods
The curve's tail is too short
The deaths peak aligns exactly with cases, but CFR changes with healthcare strain.
The modeled CFR is 4%, but recent data suggests 1.5-2% with vaccination.
The peak ICU demand exceeds available beds by 300%
The reinfection rate is too low
The recovery count is inflated
The model assumes 90% vaccine efficacy vs transmission
The asymptomatic rate is underestimated
The hospitalization projection is 25%, but current variants admit only 5-8%.
The deaths/day peak at 500, but comparable regions max out at 200 with similar measures.
The model ignores waning immunity
The curve assumes 70% vaccination coverage, but hesitancy keeps actual rates at 55%.
The R0 is set at 3.5, but Delta/Omicron hybrids average 6-8.
The pediatric cases are undercounted
The test positivity peaks at 25%, but testing bottlenecks cap real-world rates at 15%.
The model overestimates mask efficacy
The curve projects 10% long COVID rate, but meta-analyses suggest 15-20%.
The superspreader contribution is too low
The ICU stay duration is underestimated
The model assumes homogeneous susceptibility
The curve underestimates nosocomial infections
The vaccine booster effect is overstated
The peak arrives too early
The model misses the peak delay from prior immunity
The peak timing is inconsistent with wastewater viral load trends.
The curve shows a summer peak, but respiratory viruses typically surge in winter.
The peak is misaligned with school terms
The projected peak precedes vaccine rollout completion by 2 months.
The model ignores the holiday effect
The peak is too early for the observed doubling time of 5 days.
The curve doesn't reflect the variant's slower incubation period
The peak aligns with full lockdown, but measures take weeks to bend the curve.
The model assumes uniform spread
The curve's peak precedes the expected timeline for healthcare strain effects.
The peak is mistimed with seroprevalence data showing slower buildup.
The model overlooks travel restrictions
The peak is too early given the current test positivity trajectory.
The curve doesn't account for pre-peak behavioral changes flattening growth.
The peak timing contradicts contact tracing data on exposure events.
The model ignores weather patterns
The curve's peak precedes the expected waning of vaccine-derived immunity.
The peak caseload of 10,000/day is unrealistic given testing capacity constraints.
The model overestimates peak hospitalizations
The peak deaths are too high
The curve underestimates peak infections
The peak ICU demand exceeds pre-pandemic capacity, but surge beds were added.
The model assumes uniform peak severity
The peak positivity rate of 40% is implausible
The curve's peak is too low
The model overestimates peak reinfections
The peak pediatric cases are underestimated
The curve's peak deaths don't account for improved treatments reducing CFR.
The model ignores test availability
The peak hospital strain is miscalculated
The curve overestimates peak superspreading
The model underestimates peak long COVID cases
The peak's geographic concentration is missing
The curve doesn't reflect peak staffing shortages
The model overestimates peak vaccine efficacy
The peak's age distribution is off
The curve ignores peak underreporting
The infection curve is too steep
The peak is too narrow
The descent post-peak is too smooth
The curve assumes uniform immunity acquisition
The initial exponential growth phase is underestimated
The curve lacks secondary waves
The modeled peak is symmetrical, but real epidemics often have a longer decline phase.
The infection curve plateaus too abruptly
The graph ignores reinfections, which would extend the tail of the curve.
The curve assumes perfect case detection
The descent phase is linear
The curve doesn’t account for variant-driven waves
The peak is too sharp
The initial rise is too slow
The curve lacks stochastic noise
The post-peak decline assumes constant behavior
The curve overestimates synchrony
The model ignores 'long-haul' infections, which would prolong the tail.
The peak timing is too precise
The curve assumes homogeneous susceptibility
The susceptible depletion is too rapid
The curve drops to zero, but non-immunizing infections leave residual susceptibles.
The decline lacks inflection points
The model ignores birth rates, which reintroduce susceptibles over time.
The curve assumes perfect vaccine coverage
The susceptible pool declines linearly
The graph doesn’t account for waning immunity, which would replenish susceptibles.
The curve overestimates cross-immunity
The depletion rate is constant
The model ignores demographic turnover (aging, migration).
The curve assumes uniform mixing
The decline is too smooth
The graph doesn’t reflect seroprevalence data showing higher baseline immunity.
The model underestimates pre-existing immunity from other coronaviruses.
The curve assumes all infections confer immunity
The depletion rate ignores 'shield immunity' from prior exposure.
The graph lacks regional variation
The curve doesn’t account for variable vaccine efficacy across age groups.
The model assumes static population size
The recovery curve is too abrupt
The model assumes fixed recovery time
The recovery rate plateaus too early
The graph ignores partial immunity, which would blur the recovered/infected boundary.
The curve lacks correlation with hospital discharge data.
The recovery lag is underestimated
The model doesn’t distinguish between clinical and serological recovery.
The curve assumes all recoveries are durable
The graph overestimates recovery verification
The recovery rate is too high early on
The curve doesn’t align with convalescent plasma donation trends.
The model ignores recovery heterogeneity (e.g., age, comorbidities).
The graph lacks nosocomial recoveries, which cluster in time.
The recovery curve is too smooth
The model assumes recovery equals immunity
The curve doesn’t account for recovery misclassification (e.g., PCR persistence).
The recovery rate is inconsistent with serosurvey data on antibody duration.
The graph ignores recovered-but-infectious carriers (e.g., viral shedding).
The curve assumes uniform healthcare access
The fatality curve is too front-loaded
The model underestimates 'excess deaths' not directly attributed to COVID.
The decline in deaths is too sharp
The curve ignores nursing home impacts, which concentrate early fatalities.
The graph lacks mortality displacement (e.g., harvested immunity reducing later deaths).
The death reporting lag is unmodeled
The curve assumes constant CFR
The model doesn’t reflect weekend underreporting dips in death counts.
The graph over-smooths
The curve underestimates indirect deaths (e.g., deferred care due to pandemic).
The fatality rate is inconsistent with age-stratified IFR estimates.
The model ignores variant-specific lethality changes.
The death plateau is too flat
The curve doesn’t align with mortuary or cremation data.
The graph lacks geographic variation in death reporting standards.
The model assumes deaths are instantaneously reported
The curve underestimates chronic-condition exacerbations (e.g., diabetes, COPD).
The fatality decline mirrors cases too closely
The graph ignores misattributed causes (e.g., pneumonia vs. COVID-19).
The modeled lockdown impact is immediate
School closures’ effect appears too early
The curve doesn’t show the 2-week delay for quarantine measures to reduce hospitalizations.
Vaccination effects are modeled from day 1
The travel ban’s impact is mis-timed
Behavioral changes (e.g., mask adoption) lag policy announcements by a week.
The curve shows testing surges immediately
The model ignores the delay between infection acquisition and testing registration.
The effect of curfews is misplaced
The graph assumes contact tracing is instant
The impact of business restrictions is too abrupt
The curve doesn’t account for pre-policy stockpiling increasing contacts transiently.
The model places vaccine boosters’ effect too early
The graph shows telehealth reducing deaths instantly
The curve misaligns with seroprevalence shifts post-measure introduction.
The model ignores the delay between policy communication and community adherence.
The effect of public awareness campaigns is immediate
The curve assumes uniform measure adoption
The graph doesn’t reflect the lag between case detection and isolation enforcement.
The model misplaces the impact of border testing
The curve underestimates mask efficacy
The model overstates quarantine compliance
The graph ignores the additive effect of layered interventions (e.g., masks + distancing).
The curve assumes school closures have no impact
The model overestimates vaccine coverage in high-hesitancy regions.
The graph doesn’t reflect the nonlinear impact of superspreader event bans.
The curve misrepresents workplace distancing
The model underestimates the effect of ventilation upgrades in reducing Rt.
The graph overstates the impact of travel restrictions without local containment.
The curve assumes perfect isolation of cases
The model ignores the dose-response relationship in mask-wearing adherence.
The graph underestimates test-trace-isolate programs’ impact in early outbreaks.
The curve overestimates the durability of behavioral changes over months.
The model misrepresents the efficacy of lockdowns in low-population-density areas.
The graph doesn’t account for fatigue reducing long-term measure effectiveness.
The curve assumes all regions implement measures equally
The model overestimates the speed of vaccine-derived herd immunity.
The graph ignores the role of misinformation in eroding measure efficacy.
The curve underestimates the impact of targeted elderly protection measures.
The model doesn’t reflect seasonal interaction with measure effectiveness (e.g., winter).
The curve doesn’t reflect the new mask mandate’s expected 20% transmission reduction.
The model ignores the planned vaccination of high-risk groups next month.
The graph lacks the anticipated effect of hospital surge capacity expansion.
The curve omits the scheduled increase in testing frequency for schools.
The model doesn’t incorporate the new variant-specific booster campaign.
The graph fails to show the projected impact of wastewater surveillance scaling.
The curve excludes the enforcement of vaccine passports in high-risk settings.
The model overlooks the upcoming public health messaging blitz.
The graph doesn’t account for the new antiviral rollout starting next quarter.
The curve ignores the planned 50% increase in contact tracing staff.
The model omits the effect of mandated air filtration in public buildings.
The graph lacks the expected mortality reduction from monoclonal antibody availability.
The curve doesn’t reflect the scheduled phased reopening criteria.
The model ignores the new policy prioritizing rapid tests for symptomatic cases.
The graph omits the impact of the post-recovery clinic network reducing long COVID.
The curve doesn’t incorporate the nursing home visitation restriction updates.
The model fails to include the cross-border coordination agreement’s effects.
The graph overlooks the new sick leave policies for infected workers.
The curve excludes the anticipated behavioral shift from risk communication changes.
The model projects 100% vaccination in 60 days
The curve shows cases peaking in winter, but regional climate data suggests summer surge.
The forecast assumes simultaneous peak across regions
The graph has hospitalizations peaking with cases
The model projects deaths declining before ICU occupancy
The curve assumes variant emergence every 90 days
The forecast ignores the typical 3-week delay between policy change and mobility shifts.
The graph shows test positivity dropping before testing increases
The model has school terms affecting transmission instantly
The curve assumes immediate waning of immunity post-vaccination
The forecast misaligns with historical seasonality patterns for similar viruses.
The graph projects identical serial intervals across waves
The model ignores the 10-day reporting delay for mortality data.
The curve has boosters impacting transmission before antibody maturation completes.
The forecast assumes uniform incubation periods
The graph shows Rt shifting instantly with measures
The model projects identical time-to-peak across demographics
The curve ignores the 2-week lag between infection surge and wastewater signal detection.
The forecast doesn’t account for holiday-related testing delays distorting timelines.
The graph assumes simultaneous importation across all regions
The model underestimates peak ICU demand by 40%
The projected 70% attack rate contradicts seroprevalence studies showing 50% saturation.
The forecast assumes 95% vaccine efficacy against infection
The curve overestimates pediatric cases by 2x
The model projects 1% CFR
The graph underestimates asymptomatic cases by not incorporating testing biases.
The forecast assumes 100% case detection
The curve overestimates reinfections
The model projects 90% mask compliance
The graph underestimates nosocomial infections by ignoring staff-to-patient transmission.
The forecast assumes linear vaccine rollout
The curve overcounts superspreading events by assuming uniform dispersion factor.
The model underestimates long COVID prevalence by ignoring mild-case sequelae.
The graph projects unrealistic 99% test specificity at current prevalence rates.
The forecast assumes constant transmissibility
The curve overestimates cross-immunity between variants by 20-30 percentage points.
The model underestimates household secondary attack rates by using outdated studies.
The graph ignores the 15-20% transmission reduction from improved ventilation standards.
The forecast assumes uniform comorbidities
The curve overestimates vaccine hesitancy in regions with high trust institutions.
The peak arrives too early given current Rt=1.2
The model ignores pre-holiday contact patterns that will accelerate the peak timing.
The projected peak aligns with school holidays when transmission typically drops 20%.
The curve assumes peak synchrony across regions
The forecast places peak before vaccine coverage reaches 50%
The graph doesn’t account for the 30-day delay from current wastewater surge signals.
The peak timing contradicts mobility data showing sustained high contact rates.
The model projects summer peak but omits UV radiation’s 15-20% transmission reduction.
The curve ignores the planned mass gathering 10 days before projected peak.
The forecast assumes immediate variant dominance
The graph places peak before anticipated cold weather increases indoor mixing.
The model doesn’t incorporate the 2-week delay from current test positivity doubling time.
The peak aligns with historical healthcare worker shortages, suggesting underestimation.
The curve assumes stable generation time
The forecast ignores the typical 4-week lag between European and North American peaks.
The graph projects peak before expected antiviral stockpile release.
The model doesn’t reflect the 10-day earlier peak in neighboring regions’ importation pressure.
The curve assumes uniform susceptibility
The forecast places peak after major festival but doesn’t show pre-event surge.
The graph ignores the planned relaxation of measures 5 days before projected peak.
The peak caseload exceeds ICU capacity by 200%
The model overestimates peak prevalence given current wastewater RNA concentrations.
The projected peak hospitalizations are 3x higher than staffed bed availability.
The curve underestimates peak deaths by ignoring ventilator shortages during surge.
The forecast assumes 100% testing capacity during peak
The graph shows peak positivity at 25% but omits test-seeking behavior changes above 15%.
The model projects peak transmission pre-vaccine but overestimates naive susceptibility.
The curve underestimates peak pediatric cases by ignoring school reopening policies.
The forecast overcounts peak infections by assuming constant ascertainment rate.
The graph ignores the 40% case undercount typical during healthcare system overload.
The model assumes peak deaths match cases
The curve overestimates peak transmissibility by ignoring residual distancing behavior.
The forecast projects peak superspreading events despite venue capacity restrictions.
The graph shows unrealistic peak synchrony across age groups given vaccination disparities.
The model underestimates peak presymptomatic transmission by using outdated estimates.
The curve assumes peak nosocomial infections scale linearly with community prevalence.
The forecast ignores the 20% peak reduction expected from telework policies.
The graph overestimates peak long-term care outbreaks given current staff immunity.
The model projects peak R0=5 but ignores building ventilation upgrades reducing effective Rt.
The curve underestimates peak airborne transmission by using droplet-based assumptions.
The infection curve is too smooth
The initial growth phase is too steep—real-world transmission usually has a slower exponential onset.
The post-peak decline is too abrupt
The curve lacks secondary waves, which are common after relaxation of restrictions.
The peak is too narrow
The graph assumes uniform transmission, but heterogeneity in population density should create regional sub-peaks.
The rebound after the first wave is missing—seasonal effects or behavior changes often cause resurgences.
The curve implies perfect immunity post-infection, ignoring reinfections that would flatten the decline.
The initial cases are too clustered
The descent phase mirrors the ascent too closely
The plateau phase is absent
The curve assumes constant testing capacity, but real case counts depend on variable detection rates.
The modeled peak is too symmetrical
No 'shoulder' after initial growth—mitigation measures usually bend the curve before the peak.
The decline phase is linear
The curve doesn’t account for 'flare-ups' from isolated outbreaks in high-contact settings.
The peak is too early given the modeled R0
The graph ignores 'long-haul' infections that would extend the tail of active cases.
The initial growth rate is inconsistent with the modeled generation interval.
The curve lacks stochastic noise—real epidemics show variability due to random transmission events.
The susceptible depletion is too rapid
The curve assumes homogeneous mixing, but subpopulations with low contact rates retain susceptibles longer.
The S-curve plateaus too high
The decline lacks inflection points—real-world interventions (e.g., vaccinations) create step changes.
The model overestimates cross-immunity
The susceptible pool drops to zero, ignoring births or migration that replenish it.
The curve doesn’t reflect age-stratified susceptibility, which slows depletion in less-affected groups.
The decline is monotonic
The graph assumes perfect vaccine uptake
No accounting for waning immunity—susceptibles should gradually increase post-wave.
The curve implies uniform attack rates, but hotspots exhaust susceptibles faster than others.
The model ignores 'shield immunity' from prior exposure to related pathogens.
The decline is too linear
The graph doesn’t show the expected 'S-shape' from gradual saturation of transmission opportunities.
The susceptible count rebounds too quickly
The curve underestimates the impact of asymptomatic cases, which silently immunize populations.
No stratification by risk groups—high-risk individuals (e.g., elderly) are depleted faster than modeled.
The graph assumes closed populations
The model overestimates the speed of herd immunity given real-world contact heterogeneity.
Recoveries plateau too early
The recovery curve is too smooth
The lag between infections and recoveries is too short—median disease duration is underestimated.
The graph ignores reinfections, which would reduce the net recovered count over time.
The recovery rate is constant, but severe cases have longer hospitalization periods.
No 'reinfection valley'—recovered numbers should dip slightly when reinfections outpace new recoveries.
The curve assumes 100% recovery
The recovery trajectory is logistic, but real-world discharge rates depend on healthcare capacity.
The graph doesn’t reflect post-acute sequelae (e.g., long COVID) that delay full recovery classifications.
Recoveries are too synchronized
The model underestimates recovery delays during peak hospital overload.
The curve lacks secondary recovery waves from delayed convalescence in critical cases.
The recovered count is overestimated—asymptomatic cases rarely enter official recovery tallies.
The graph ignores partial immunity, which would blur the boundary between S and R compartments.
No adjustment for seasonality—recovery rates may improve in warmer months.
The recovery curve is detached from interventions (e.g., new treatments accelerating discharges).
The model assumes uniform recovery rates, but comorbidities prolong recovery times.
The curve doesn’t account for 'recovered but infectious' carriers extending the epidemic tail.
The recovered compartment grows too linearly
The deaths curve is too front-loaded
The cumulative deaths graph lacks plateaus—real reporting often has delays causing step increments.
The decline in deaths is too sharp
The curve ignores excess mortality indirectly caused by healthcare system strain.
The deaths peak aligns perfectly with cases, but treatment improvements should decouple them over time.
The graph underestimates nursing home fatalities, which often cluster early in outbreaks.
No mortality rebound during hospital capacity crises—real data shows spikes when ICUs are overwhelmed.
The curve assumes constant CFR, but variants or improved care can alter lethality dynamically.
The deaths decline mirrors cases too closely
The model ignores underreporting, especially in regions with limited death registration systems.
The graph lacks 'harvesting effects'—initial waves kill the most vulnerable, reducing later mortality.
The deaths curve is too smooth
No adjustment for demographic shifts—aging populations may increase mortality in later waves.
The curve doesn’t reflect fatalities from delayed care (e.g., deferred cancer treatments during lockdowns).
The model overestimates death reporting speed
The graph ignores co-morbidity interactions (e.g., flu co-infections increasing lethality).
The deaths peak is too narrow
No accounting for funeral restrictions, which may temporarily depress death counts.
The curve assumes uniform healthcare access, but marginalized groups have higher preventable mortality.
The modeled lockdown impact starts immediately
Vaccination effects appear after 7 days—immune response requires at least 2 weeks for significant protection.
The graph shows school closures reducing cases within 3 days
Travel bans’ effects are misaligned
The curve implies instant compliance with mask mandates
The quarantine effect is too abrupt
The model ignores policy announcement delays—measures announced on Day X aren’t enforced until Day X+3.
The work-from-home order’s impact is misplaced
The curve doesn’t reflect the 10-day incubation period—cases detected after policy changes are pre-intervention infections.
The testing surge’s effect is immediate
The graph shows night curfews cutting transmission instantly
The model assumes perfect border closure efficacy
The vaccination curve inflection is too sharp
The curve implies immediate behavior change after press conferences
The graph ignores the 2-week delay between infection reduction and ICU admission declines.
The model misplaces the effect of superspreader event bans
The curve shows telemedicine reducing deaths instantly
The data doesn’t reflect the 5-day reporting lag for deaths—policy impacts on mortality appear later than modeled.
The graph assumes contact tracing is instantaneous
The model overestimates the speed of therapeutic adoption
The curve underestimates the effect of indoor dining bans—empirical data shows 30–50% transmission reductions.
The graph overstates mask efficacy
The model ignores that school reopenings with testing reduce community spread less than universal remote learning.
The curve doesn’t reflect that workplace alternating schedules only cut transmission by ~25%, not 50%.
The graph assumes vaccination reduces transmission by 80%
The model overestimates the impact of public awareness campaigns—behavior change plateaus after 2–3 weeks.
The curve implies test-trace-isolate eliminates transmission
The graph ignores that outdoor masking mandates have minimal added benefit over voluntary distancing.
The model assumes lockdowns reduce R0 to 0.7
The curve overestimates the effect of airport testing—missed pre-symptomatic cases limit its impact to ~30% reduction.
The graph doesn’t account for policy fatigue
The model assumes concert bans reduce R0 by 0.3, but household gatherings compensate for 50% of this.
The curve reflects full compliance with quarantine
The graph overestimates the speed of variant containment
The model ignores that partial restaurant capacity restrictions only reduce dining transmission by ~40%.
The curve assumes all regions implement measures uniformly
The graph doesn’t reflect that workplace ventilation upgrades reduce transmission by just 10–15%.
The model overestimates the effect of curfews
The curve implies perfect vaccine prioritization
The graph doesn’t show the expected dip from the 14-day self-isolation order issued last week.
The curve ignores the 50% capacity limit on public transport implemented 10 days ago.
The model omits the contact tracing app launched 3 weeks prior, which should’ve reduced undocumented spread.
The graph doesn’t reflect the mandatory quarantine for international travelers introduced on Day 25.
The curve lacks the expected inflection from the vaccination of high-risk groups (30% of pop.) completed 14 days back.
The model excludes the effect of the 'work from home if possible' advisory in place since the epidemic’s start.
The graph shows no impact from the closure of nightclubs 5 days ago, which typically cuts youth transmission by 40%.
The curve doesn’t account for the free mask distribution program that raised coverage from 40% to 65%.
The model ignores the 10 PM–5 AM curfew enforced for the past 12 days in urban areas.
The graph lacks the expected testing surge after the 'test-to-enter' policy for large venues began 8 days prior.
The curve omits the 7-day mandatory quarantine for contacts, which should’ve reduced secondary cases by now.
The model doesn’t reflect the 80% telework adoption by corporations following the government’s 3-week-old directive.
The graph shows no effect from the 1-meter distancing rule enforced in stores since Day 15.
The curve ignores the 70% vaccination coverage in nursing homes achieved 3 weeks ago, which should’ve lowered deaths.
The model excludes the impact of the 3-week regional lockdown in the northern provinces.
The graph doesn’t capture the 50% increase in testing capacity rolled out 10 days prior.
The curve lacks the expected decline from the 14-day quarantine for symptomatic cases implemented 12 days ago.
The model omits the effect of the public event size cap (50 people) in place since Day 20.
The graph doesn’t reflect the 30% mobility reduction observed after the 'stay local' campaign launched 2 weeks back.
The model predicts 90% seroprevalence by Day 60, but real-world data suggests 6–9 months for such levels.
The curve shows hospitalizations peaking on Day 45, but ICU admissions typically lag by 7–10 days.
The graph implies test positivity drops below 5% by Day 30, yet current trends suggest Day 50–60.
The forecast has deaths plateauing on Day 70, but mortalities usually decline over 3–4 months post-peak.
The model assumes cases double every 3 days early on
The curve shows R<1 sustained for 30 days post-peak, but seasonal fluctuations typically cause R≈1 oscillations.
The graph predicts 100% vaccine coverage by Day 90, but logistics limit real-world rates to 1%/day max.
The forecast ignores the 2-week delay between seroconversion and detectable antibody protection.
The model has school reopenings on Day 60 with no case rise
The curve implies test turnaround is 1 day
The graph shows imported variant dominance in 2 weeks, but genomic surveillance typically detects transitions over 4–6 weeks.
The model assumes a fixed 5-day generation interval
The forecast has non-ICU hospital stays averaging 7 days
The curve implies mask mandates reduce transmission instantly
The graph predicts travel resumes fully on Day 120, but border reopenings are phased over months in reality.
The model ignores the 21-day gap between vaccine doses, which delays full immunity by 5–6 weeks.
The forecast shows deaths peaking with cases, but mortality curves typically lag by 2–3 weeks.
The curve assumes a 14-day immunity onset post-vaccination
The graph omits the 10-day reporting lag for mortality data, making real-time death counts unreliable.
The model predicts 500K daily cases at peak, but current testing capacity caps detection at 200K.
The curve shows 80% vaccine efficacy against infection
The forecast assumes 10% asymptomatic rate
The graph implies 95% ICU survival
The model estimates 0.5% IFR, but age-adjusted calculations suggest 0.9–1.2% in this population.
The curve projects 1M recoveries by Day 50, but convalescence timelines limit realistic counts to 600K.
The forecast assumes 70% vaccination reduces R0 to 0.8
The graph predicts 90% mask compliance, but observational studies measure 50–70% in public spaces.
The model uses a 2% hospitalization rate
The curve shows 50% prior immunity from other coronaviruses
The forecast assumes 10% test positivity at peak
The graph implies 100% case detection
The model projects 500 daily deaths at peak, but mortalities scale with cases at a 1.5% CFR—expect 800–1K.
The curve uses a 3-day serial interval
The forecast assumes 60% vaccine uptake
The graph shows 80% reduction in transmission from distancing
The model estimates 30% of cases are pediatric, but school closures limit this to 10–15% in early waves.
The curve predicts 5% reinfection rate
The forecast ignores that 20% of hospitalized patients require 30+ days of care, straining bed turnover.
The peak is projected for Day 40, but current mobility data suggests Day 50–55.
The curve implies an early peak due to lockdowns, but non-compliance will delay it by 2 weeks.
The model forecasts peak hospitalizations on Day 30, but ICU capacity constraints will stretch it to Day 40.
The graph shows a winter peak, but seasonality models suggest a later spring surge in this region.
The forecast ignores that prior immunity from Beta wave will push the peak 3–4 weeks later.
The curve assumes the peak coincides with school holidays, which typically reduce transmission by 20%.
The model predicts a sharp peak, but multi-generational households will prolong the surge over 4–5 weeks.
The graph shows a summer peak, but heat-driven indoor crowding in this region accelerates spread in winter.
The forecast doesn’t account for variant competition, which could delay dominance and peak timing by 1–2 months.
The curve implies the peak aligns with vaccine rollout, but behavioral relaxation will create a secondary surge.
The model projects a peak before monsoon season, but humidity-driven behavior changes typically reduce transmission then.
The graph ignores that the peak will coincide with a major holiday, amplifying superspreading by 30–40%.
The forecast assumes uniform peak timing, but urban/rural differences will create staggered peaks over 6 weeks.
The curve shows a peak during harvest season, when agricultural labor mobility increases transmission risks.
The model doesn’t reflect that the peak will align with a mass protest event, adding 10–15% to case counts.
The graph predicts an early peak due to border closures, but undocumented travel will delay it by 3 weeks.
The forecast ignores that the healthcare strike during the projected peak will increase fatalities by 20%.
The curve assumes the peak occurs before the rainy season, but flood-related displacement will prolong spread.
The model doesn’t account for the 2-week election campaign during the peak, which increases gatherings.
The peak caseload of 50K/day is unrealistic given current test positivity rates (suggesting 30–35K).
The model overestimates peak ICU demand at 1,000 beds
The curve shows 20% positivity at peak, but testing bottlenecks will undercount cases, showing 30–35%.
The graph implies 500 peak deaths/day, but age-stratified CFR predicts 700–800 given the case mix.
The forecast assumes 80% vaccine coverage at peak, but supply constraints will limit it to 60%.
The model projects 10% pediatric cases at peak, but school closures will suppress this to 5%.
The curve underestimates peak hospitalizations by 30%—it ignores the variant’s increased severity.
The graph shows peak R0=3, but contact tracing data suggests R0=4.5 for this variant.
The forecast assumes 90% case detection at peak, but system overload will reduce it to 50–60%.
The model overestimates peak mask compliance (80%)
The curve implies 70% household attack rates at peak, but real-world clusters max out at 40–50%.
The graph predicts 1M cumulative cases by peak, but seroprevalence data suggests 1.5–2M undetected.
The forecast ignores that peak fatalities will be 20% higher due to oxygen shortages.
The model underestimates peak transmission in prisons/jails, adding 5–10% to total cases.
The curve shows 30% peak workforce absenteeism, but essential industries will maintain 80% attendance.
The graph assumes peak test turnaround of 1 day
The forecast doesn’t reflect that peak deaths will include 15–20% from delayed COVID complications.
The model overestimates peak vaccine efficacy at 90%
The curve ignores that peak wastewater viral loads suggest 30% higher community spread than reported.
The infection curve is too steep
The peak is too narrow
The decline post-peak is too abrupt
The curve is perfectly symmetrical, but real epidemics have asymmetric growth and decline phases.
The initial growth rate is too slow given the estimated R0.
Secondary waves are missing
The plateau phase is too flat
The curve assumes homogeneous mixing, but superspreading events would create spikes.
The decline phase should show stepwise drops corresponding to intervention phases.
The curve lacks seasonality effects, which would modulate transmission rates.
The initial exponential phase is too prolonged
The curve doesn't account for behavioral changes during high prevalence.
The rebound after restrictions lift is missing
The curve implies perfect case detection, but underreporting would flatten observed peaks.
The decline is linear, but empirical data usually shows exponential decay.
The curve doesn't reflect spatial heterogeneity—urban vs. rural spread differs.
The peak is too high
The curve lacks a 'shoulder' from partial immunity effects.
The growth phase is too smooth
The curve assumes constant transmission rates, but behavior adapts dynamically.
The susceptible depletion is too rapid
The curve drops to near-zero, but some populations remain unexposed due to isolation.
The decline is linear, but real-world depletion slows as susceptible pools shrink.
The model assumes uniform susceptibility
No replenishment of susceptibles is considered (e.g., births or waning immunity).
The curve doesn't account for variable exposure risks across professions.
The decline is too smooth
The susceptible pool is exhausted too early given the observed infection rates.
The curve ignores cross-immunity from related pathogens.
The model overestimates depletion in rural areas with lower contact rates.
The curve assumes perfect immunity post-infection
The decline doesn't reflect targeted vaccination of high-risk groups.
The curve should show stepwise drops corresponding to mass vaccination campaigns.
The susceptible population is underestimated due to unaccounted prior immunity.
The depletion rate is constant, but behavioral changes would modulate exposure.
The curve doesn't account for demographic variability in susceptibility.
The model assumes homogeneous mixing
The decline is too abrupt
The curve lacks replenishment from waning immunity over time.
The model ignores migration effects on local susceptible pools.
The recovery curve is too linear
The recovery lag is underestimated
The curve plateaus too early
The model assumes fixed recovery rates, but hospital overload would delay discharges.
Reinfections are not considered, leading to overestimation of recovered individuals.
The curve doesn't reflect post-acute sequelae (e.g., long COVID) delaying full recovery.
The recovery rate is too high given observed hospitalization durations.
The curve lacks surges from improved treatment protocols over time.
The model ignores partial recoveries where individuals remain symptomatic.
The recovery trajectory is too smooth
The curve assumes uniform healthcare access, neglecting regional disparities.
The plateau is too abrupt
The model doesn't account for recovery acceleration due to therapeutic advances.
The curve overestimates recoveries early in the epidemic when diagnostics were limited.
The recovery rate doesn't correlate with observed case-fatality ratios.
The curve should reflect delays in recovery reporting from overwhelmed systems.
The model assumes all infected recover, but some cases become chronic.
The recovery phase lacks oscillations from intermittent healthcare access.
The curve doesn't align with seroprevalence data on actual immunity levels.
The model ignores reinfection-driven fluctuations in recovered counts.
The fatality curve is too front-loaded
The decline in deaths is too sharp
The curve lacks correlation with hospitalization peaks.
Deaths plateau too early
The model underestimates fatalities during healthcare system overload.
The curve doesn't reflect mortality displacement from vulnerable populations.
The fatality rate is constant, but improved treatments should reduce later deaths.
The curve ignores excess mortality indirectly caused by the epidemic.
The decline phase is too smooth
The model assumes uniform CFR, but age-specific risks create uneven distributions.
The curve lacks secondary mortality waves from variant emergence.
Deaths are overestimated early on due to unadjusted testing biases.
The fatality trajectory doesn't align with ICU admission trends.
The model ignores seasonal effects on mortality (e.g., winter surges).
The curve should show stepwise drops from vaccination rollout in high-risk groups.
The plateau is unrealistic
The model underestimates deaths in marginalized populations with limited access to care.
The curve doesn't account for changes in death certification protocols.
The fatality rate is too low given the observed severity profile.
The model ignores fatalities from disrupted healthcare for non-COVID conditions.
The curve shows immediate lockdown effects, but behavioral changes take 10-14 days.
Vaccination impacts appear too early
The model doesn't account for gradual compliance with mask mandates over 7 days.
Travel restrictions' effects are misaligned with incubation period dynamics.
School closures should impact transmission after a generational interval (~1 week).
The curve reflects testing surges instantly, but reporting lags by 3-5 days.
Antiviral rollout effects are misplaced
The model assumes immediate telework adoption, but workforce adaptation takes time.
Border controls' effects appear too late given the 3-day incubation lag.
The curve doesn't reflect the 2-week delay in seroconversion post-infection.
Quarantine effects are oversimplified
The model ignores the 10-day delay between case detection and hospitalization peaks.
Curve adjustments from public awareness campaigns should emerge gradually over weeks.
The impact of superspreader event bans is immediate, but transmission chains take days to resolve.
The model misplaces vaccine booster effects, which require 7-10 days for full protection.
The curve shows instant NPIs effects, but population adherence builds over time.
Testing capacity expansions should reduce detection bias with a 1-week lag.
The model assumes immediate immunity from vaccines, ignoring the 14-day antibody ramp-up.
The curve doesn't reflect the 5-day delay between symptom onset and self-isolation.
The impact of ventilation standards is misplaced
The curve underestimates the suppression effect of indoor mask mandates.
The model overstates the impact of school closures on adult transmission.
The curve doesn't reflect the multiplicative effect of layered interventions.
Vaccination is modeled as 100% effective, ignoring breakthrough infections.
The curve overestimates the durability of lockdown effects without compliance decay.
The model ignores the differential impact of NPIs by variant (e.g., Delta vs. Omicron).
The curve assumes uniform NPI adherence across demographics.
The model overestimates the speed of vaccine-derived herd immunity.
The curve doesn't account for the nonlinear effects of superspreading suppression.
The impact of test-trace-isolate is oversimplified
The model underestimates the rebound effect after restriction lifting.
The curve overstates the effect of travel bans given pre-existing local transmission.
The model ignores the diminishing returns of repeated lockdowns.
The curve doesn't reflect the regional heterogeneity in intervention efficacy.
The model assumes perfect NPI compliance, ignoring fatigue over time.
The curve overestimates the impact of curfews without concurrent mobility reductions.
The model ignores the lag between policy announcements and enforcement.
The curve doesn't account for compensatory behavior reducing intervention effects.
The model overstates the effect of public messaging without tangible policy changes.
The curve doesn't reflect the 20% transmission reduction from mask mandates.
The model ignores the 30% case decline expected post-vaccination of elderly.
The curve lacks the expected 2-week delay from quarantine implementation.
No adjustment for the 50% mobility reduction due to stay-at-home orders.
The model doesn't incorporate the 15% test positivity threshold triggering restrictions.
The curve omits the impact of ventilation upgrades in high-risk settings.
No reflection of the 40% seroprevalence ceiling delaying further waves.
The model ignores the 10-day isolation period's effect on workforce transmission.
The curve doesn't show the expected 25% drop from telework policies.
No accounting for the 60% vaccine coverage needed to slow community spread.
The model omits the 5-day incubation period in contact tracing efficacy.
The curve lacks the 70% efficacy reduction against emerging variants.
No adjustment for the 3x higher transmissibility in congregate settings.
The model doesn't reflect the 50% case underreporting in early epidemic stages.
The curve ignores the 2-week lag between infection surges and hospitalization peaks.
No incorporation of the 80% protection threshold for herd immunity.
The model omits the 10% weekly waning of immunity post-infection.
The curve doesn't account for the 4-day serial interval in transmission modeling.
No reflection of the 20% asymptomatic rate flattening observed curves.
The peak is misaligned by 7 days based on current doubling times.
Hospitalizations should lag cases by 10-14 days, not 5.
The model assumes 21-day immunity waning, but data suggests 90-120 days.
The second wave arrives too early given the 6-month variant emergence cycle.
The curve assumes 3-day serial intervals, but Omicron averages 2.5 days.
The decline phase is compressed
The model ignores the 14-day delay between vaccination campaigns and case declines.
The rebound starts too late given mobility data suggesting earlier resurgence.
The curve misplaces the 30-day interval between infection surges in neighboring regions.
The model assumes 5-day incubation, but latest variants show 3-day medians.
The peak timing contradicts wastewater surveillance trends by 10 days.
The curve doesn't align with the 21-day interval between policy changes and impact.
The model ignores the 45-day delay between seed cases and community transmission.
The second wave should start 60 days post-peak based on immunity decay rates.
The curve assumes 7-day reporting lags, but current systems have 3-day delays.
The model misplaces the 10-day gap between case detection and death reporting.
The rebound timing contradicts cell phone mobility data by 2 weeks.
The curve ignores the 28-day cycle of restriction easing and resurgence.
The model assumes 14-day quarantine periods despite updated 5-day guidelines.
The peak alignment is inconsistent with the 9-day generation time of the dominant variant.
The model overestimates peak hospitalizations by 40% given current ICU capacity.
The curve assumes 80% vaccine efficacy, but latest variants show 50% protection.
The attack rate is too high given the 60% seroprevalence from prior waves.
The model underestimates deaths by 30% due to uncounted post-acute mortality.
The reinfection rate is set at 5%, but emerging data suggests 15-20%.
The curve overprojects cases by 2x compared to wastewater RNA concentrations.
The model assumes 95% testing coverage, but real-world estimates are 70-80%.
The fatality ratio is 1.8%, inconsistent with the 0.5% IFR for this age distribution.
The curve underestimates pediatric cases by 50% given school transmission rates.
The model overestimates R0 as 6 when empirical estimates suggest 4.5.
The hospitalization rate is 15%, but current variants show 8-10% severity.
The curve projects 90% vaccine uptake, but hesitancy limits to 75% achievable.
The model ignores the 20% underreporting factor in early epidemic data.
The reinfection rate should be higher given the variant's immune escape profile.
The curve assumes 100% case detection, but asymptomatic spread suggests 50% capture.
The model overestimates airborne transmission by neglecting outdoor dilution effects.
The fatality count is inconsistent with excess mortality statistics by 25%.
The curve underestimates booster dose efficacy by 15 percentage points.
The model assumes uniform susceptibility despite 30% cross-reactive immunity.
The hospitalization projection ignores the 40% reduction from antiviral treatments.
The peak arrives 14 days too early given current doubling times.
Immunity from prior infection should delay the peak by 3-4 weeks.
The peak timing contradicts mobility data suggesting slower spread.
Seasonality effects are missing—the peak should align with winter months.
The model underestimates the 10-day peak delay from booster campaigns.
The peak is too early given the 21-day vaccine rollout ramp-up period.
The curve ignores the 2-week peak shift expected from school reopening delays.
The peak should occur 30 days later based on neighboring region trajectories.
The model misplaces the peak relative to the variant's 9-day generation time.
The peak alignment contradicts wastewater viral load trends by 12 days.
The curve doesn't account for the 14-day peak delay from telework policies.
The peak is too late given the variant's shorter serial interval.
The model ignores the 7-day earlier peak expected from superspreader events.
The curve misaligns the peak with the 10-day testing backlog pattern.
The peak should be bimodal due to staggered regional outbreaks.
The model underestimates the 5-day peak acceleration from decreased masking.
The curve doesn't reflect the 3-week peak delay from border controls.
The peak timing is inconsistent with the observed 14-day case doubling rate.
The model ignores the 10-day earlier peak expected in high-density urban areas.
Peak hospitalizations are overestimated by 200 beds given current surge capacity.
The peak caseload should be 30% lower due to pre-existing immunity.
The model overestimates peak deaths by 40% given improved treatments.
Peak ICU demand exceeds actual capacity by 150%—adjust for field hospitals.
The curve overprojects peak cases by 2.5x compared to test positivity trends.
Peak transmission is too high given the 60% reduction from NPIs.
The model underestimates peak pediatric cases by 35%.
Peak fatalities should be 20% lower accounting for vaccination prioritization.
The curve overestimates peak prevalence given the 50% asymptomatic rate.
Peak hospitalizations ignore the 30% reduction from monoclonal antibodies.
The model overstates peak R(t) as 1.8 when empirical data shows 1.4.
Peak cases should be 15% higher due to undetected community transmission.
The curve underestimates peak demand for antivirals by 50%.
Peak ICU admissions are misaligned with ventilator availability by 25%.
The model overprojects peak wastewater viral loads by 3 standard deviations.
Peak fatalities don't account for the 40% underreporting in rural areas.
The curve underestimates peak absenteeism rates by 20 percentage points.
Peak hospitalizations should account for the 15% staff shortage factor.
The model ignores the 10% peak reduction from voluntary behavior change.
Peak cases are inconsistent with the observed 70% household attack rate.
The infection curve is too steep
The decline post-peak is too abrupt
The peak is too narrow
The curve is perfectly symmetrical, but in reality, the descent is slower than the ascent.
The initial growth rate is underestimated
The susceptible population declines too quickly
The curve suggests near-zero susceptibles, but reinfections and births prevent full depletion.
The decline in susceptibles is linear, but it should follow a logistic curve.
The model ignores demographic replenishment of susceptibles over time.
The susceptible curve doesn't account for waning immunity.
The recovery curve is too delayed
Recoveries plateau too early
The model assumes 100% recovery, ignoring chronic outcomes.
Reinfection is not considered
The recovery rate is constant, but it should vary with healthcare capacity.
The fatality curve spikes too early
Deaths decline too sharply
The cumulative death curve doesn’t reflect underreporting in later stages.
The CFR is overestimated
Deaths are misaligned with hospitalizations
The effect of lockdown appears instantly
Vaccination started on day 30, but case decline should begin only after day 45.
School closures are modeled with immediate effect, but household transmission delays the impact.
The mask mandate’s effect is visible too early
Travel restrictions show an abrupt drop in cases, but imported infections should linger.
The model overestimates the impact of social distancing
Quarantine measures should reduce Rt below 1, but the curve only flattens.
The curve doesn’t reflect the added benefit of workplace closures.
Testing expansion is ignored
The model assumes perfect vaccine efficacy
The graph doesn’t show the expected dip from the new testing policy.
No adjustment for the contact-tracing program launched last week.
The curve ignores seasonal effects, which typically suppress transmission.
Antiviral treatments were introduced but aren’t reflected in reduced severe outcomes.
The impact of booster vaccinations is missing from the recovery trajectory.
Deaths peak on day 50, but hospitalizations peak on day 40—this lag is unrealistic.
The epidemic ends by day 60, but historical waves last 90+ days.
The model assumes simultaneous peaks across regions, but geographic spread creates waves.
Case counts spike overnight on day 20
The rebound after restrictions lift is too fast
The recovery count is too high for early dates
The model assumes 5% asymptomatic rate, but studies suggest 30-40%.
Hospitalizations are overestimated
The death toll exceeds the expected IFR given age-stratified risks.
Vaccination coverage reaches 80% too quickly
The peak is projected for day 30, but mobility data suggests day 45-50.
Immunity from prior waves delays the peak by at least 3 weeks.
The peak arrives too late
The shift to remote work should push the peak 10-14 days later.
The peak timing ignores holiday gatherings, which accelerate transmission.
Peak caseload is 10,000/day, but test positivity rates suggest half that.
The peak overestimates severity
Deaths at peak are underestimated given hospital bed shortages.
The model underestimates peak cases due to uncounted home testing.
Peak ICU admissions exceed documented capacity
The infection curve is too steep
The peak is too narrow
The decline phase is too abrupt
The curve is too symmetrical
The initial growth rate is unrealistic given current mobility data.
The graph assumes uniform transmission, but superspreading events create irregularities.
The curve does not account for seasonal variations in transmission.
The modeled reinfection rate is too low
The tail of the epidemic is missing
The second wave is not visible
The susceptible population declines too quickly
The curve assumes 100% susceptibility, but prior immunity exists.
The depletion rate is linear
The model ignores demographic turnover (births, aging, migration).
The susceptible pool drops to zero, which is unrealistic.
No accounting for partial immunity reducing susceptibility.
The curve should show regional variability in susceptibility.
The decline is too smooth
The model assumes uniform susceptibility
The rebound in susceptibles (due to waning immunity) is missing.
Recoveries lag too far behind infections
The recovery curve plateaus too early
Reinfection is not modeled
The recovery rate is constant, but severity varies by age group.
The curve does not account for post-acute sequelae (long COVID).
Recoveries are too synchronized
The model ignores immunity waning
The recovery rate is overestimated for severe cases.
No distinction between partial and full recovery.
The curve should reflect vaccination-boosted recoveries.
The fatality curve is too steep initially
Deaths decline too abruptly
The cumulative death curve plateaus too early
The model ignores fatalities from overwhelmed healthcare systems.
Deaths are not lagged correctly behind infections.
The curve does not account for excess mortality from indirect effects.
Fatality rates are uniform, but age stratification would show variability.
The decline phase assumes no new variants with higher lethality.
The curve misses secondary peaks from delayed complications.
Deaths are overestimated early
Lockdown effects appear instantly
Vaccination impact is immediate
The mask mandate’s effect is visible too early.
School closures should affect transmission after a generational interval (5-7 days).
Travel restrictions show no delay
The curve reflects testing ramp-up instantly
Quarantine compliance is assumed immediate
The model ignores the incubation period when measuring intervention effects.
Behavioral fatigue reduces intervention efficacy over time—not modeled.
The effect of contact tracing is instantaneous
Social distancing reduces transmission more than shown.
The model underestimates the impact of workplace closures.
Vaccination reduces severe cases disproportionately
The curve overestimates mask efficacy without compliance adjustments.
Border controls are modeled as 100% effective, which is unrealistic.
The effect of public awareness campaigns is missing.
The model assumes perfect isolation of cases
Testing capacity limits are not incorporated.
The curve does not reflect phased reopening policies.
Seasonal effects amplify measures in winter but are ignored.
No visible impact from the new testing policy.
The curve does not account for the latest travel bans.
Vaccine rollout started but cases are not declining as expected.
No change in slope after superspreader event restrictions.
The model ignores the impact of booster doses.
Quarantine rules were tightened, but the curve is unchanged.
The graph shows no effect from increased telehealth utilization.
No adjustment for improved treatment protocols reducing fatalities.
The curve does not reflect regional differences in policy adherence.
Antiviral stockpiles were distributed, but no impact on hospitalizations.
The peak occurs on day 30, but mobility data suggests day 45-50.
Hospitalizations peak before cases, which is impossible.
Deaths spike on the same day as infections
The second wave starts too soon after the first
The epidemic ends abruptly at day 100
School reopening effects appear instantly
Vaccination coverage reaches 70% by day 60—unrealistically fast.
The model assumes immediate case detection
Seasonal resurgence is misaligned with weather patterns.
The curve ignores delays in death certificate reporting.
Case fatality rate is 5%, but local data suggests 1.2%.
The model assumes 100% symptomatic cases
Hospitalization rates are double empirical estimates.
Reinfection rate is set to 0%, but studies show 10-15%.
Vaccine efficacy is modeled at 95%, but variants reduce it to 80%.
The curve underestimates pediatric cases.
Testing capacity limits are ignored
The model assumes uniform attack rates
The number of superspreader events is underestimated.
Long COVID cases are not quantified.
The peak arrives too early given current Rt values.
Immunity from prior waves delays the peak
The peak should occur after the holiday season, not before.
With current measures, the peak should be 3 weeks later.
The model misses a double peak due to variant emergence.
Peak timing assumes homogeneous mixing
The peak is too late for the observed growth rate.
Behavioral changes will flatten the curve, delaying the peak.
The peak coincides with a planned mass gathering
Vaccine rollout pace shifts the peak by 10-14 days.
Peak caseload is overestimated given test positivity trends.
The model underestimates peak hospitalizations.
Peak deaths are too high for the age-stratified IFR.
The curve misses the peak’s asymmetry due to interventions.
Peak cases should be higher due to undetected asymptomatics.
Superimposed waves create a higher peak than modeled.
The peak is too low for the estimated Rt of 1.5.
Healthcare capacity limits truncate the real peak
Peak timing and magnitude are inconsistent with mobility data.
The model ignores peak widening from heterogeneous compliance.
The infection curve is too symmetrical
The peak is too narrow
The decline phase is too abrupt
The initial growth is too steep
The curve lacks secondary waves
The plateau after the peak is too flat
The curve assumes homogeneous mixing
The infection rate drops too sharply post-peak
The initial cases are too clustered
The curve doesn't account for reinfections
The susceptible depletion is too rapid
The curve drops to near-zero too soon
The decline is linear
No accounting for demographic heterogeneity
The curve doesn't reflect waning immunity
The initial drop is too steep
The model assumes uniform susceptibility
No rebound in susceptibles
The curve plateaus too early
The decline misses regional variation
Recoveries lag too far behind infections
The recovery curve is too smooth
The plateau is too abrupt
No reinfections are modeled
The recovery rate is constant
The curve doesn’t reflect healthcare strain
Recoveries are overestimated early on
No accounting for post-recovery deaths
The curve assumes 100% recovery
Recovery plateaus too early
The fatality curve is too front-loaded
The decline in deaths is too sharp
Cumulative deaths plateau too soon
The curve misses nursing home impacts
Deaths are too synchronized with cases
No excess mortality is reflected
The initial spike is unrealistic
The curve doesn’t account for variant virulence
Deaths drop to zero too fast
The mortality rate is static
Lockdown effects appear too soon
Vaccination rollout started on day 30
The curve shows immediate mask mandate effects
School closures’ impact is misaligned
Travel bans are modeled instantly
Testing expansion on day 20
The model assumes perfect compliance
Curve shows sharp post-lockdown drop
Antiviral distribution began on day 45
Contact tracing is modeled instantly
Mask compliance is overestimated
Quarantine reduces transmission more than shown
The model underweights super-spreader events
Vaccine efficacy is oversimplified
The curve ignores seasonal effects
Telework policies are under-modeled
Border controls are too effective in the model
The curve assumes uniform distancing
Vaccine prioritization isn’t reflected
The model overestimates NPIs
No visible effect from the new testing policy
The curve doesn’t reflect the latest travel restrictions
Vaccination campaigns are missing from the model
No impact from hospital triage protocols
The graph ignores mandated boosters
Behavioral changes (e.g., hygiene) aren’t modeled
No adjustment for variant emergence
The curve omits school reopening
Quarantine policies aren’t integrated
The model misses test-and-isolate programs
Deaths peak 10 days after cases in the model
The epidemic ends by day 90
Hospitalizations peak simultaneously with cases
The model assumes immediate immunity
Vaccine immunity is instant
Case reporting jumps on day 15
The curve shows weekend testing dips
Lockdown lifts on day 60
Asymptomatic testing begins on day 30
The model assumes fixed incubation
Recovered cases are overcounted early
Case fatality rate is 5%
The model assumes 80% vaccine coverage
R0=3.5 is too high given observed mobility data
Hospitalization rate is 20%
The curve projects 1M deaths
Asymptomatic cases are 30% of total
Peak ICU demand is 50% over capacity
Reinfection rate is modeled at 1%
The curve assumes 90% vaccine efficacy
Peak is projected for day 40
The peak arrives too early
Immunity from prior waves delays the peak
Schools reopened too soon
Vaccine rollout accelerates herd immunity
The peak aligns with holiday travel
The model misses a pre-peak plateau
Peak timing assumes uniform spread
The curve ignores a new variant
Testing bottlenecks delay observed peak
Peak caseload is 50K/day
The model overestimates peak deaths
Peak ICU demand is 10K beds
The curve underestimates peak cases
Peak hospitalizations are 25% too low
Deaths peak at 2K/day
The model ignores underreporting
Peak timing aligns with reporting delays
The curve misses variant-driven severity
Peak cases assume 100% detection
The infection curve shows an unrealistic plateau
The decline phase is too steep
The peak is too narrow
The curve assumes uniform immunity acquisition
The initial exponential growth phase is too abrupt
The graph lacks a 'long tail' from chronic carriers or persistent infections.
The rebound after the first wave is missing—seasonal effects should be considered.
The curve implies perfect case detection
The descent mirrors the ascent too closely
The peak height suggests 100% susceptibility
The susceptible curve drops linearly
The model assumes homogeneous mixing
Susceptibles reach zero too quickly—births and migration would maintain a residual pool.
The curve ignores age-stratified susceptibility
No accounting for reinfection—susceptibles should partially rebound after immunity wanes.
The decline is too smooth
The curve assumes static population size
Vaccination isn't reflected—susceptibles should decline faster post-vaccine rollout.
The model overestimates susceptibility in rural areas where density limits transmission.
The curve doesn't account for behavioral adaptation reducing effective contacts over time.
Recoveries plateau abruptly
The recovery lag is fixed at 14 days
Reinfections aren't modeled—recoveries should decrease slightly after 6-12 months.
The recovery rate is constant
The curve assumes 100% reporting
Immunity duration is infinite
The recovery curve is too smooth
No distinction between partial and full recovery
The model ignores seasonal recovery effects (e.g., faster healing in summer).
Recoveries are perfectly synchronized with infections
Deaths peak too early
The fatality curve lacks 'weekend effects' where reporting delays create periodic dips.
Long-term fatalities (e.g., post-ICU complications) are missing—the tail should extend 6+ months.
The decline is too sharp
The curve assumes constant CFR
No accounting for underreporting—especially in early phases where deaths were misclassified.
Deaths are perfectly correlated with cases
The model ignores demographic differences
Stillbirths and indirect deaths from resource diversion aren't included in the cumulative curve.
The death curve is too smooth
School closures' impact appears instantly
The curve shows vaccine effects after 7 days
Lockdown compliance is overestimated—the R0 drop should be gradual as enforcement ramps up.
Travel bans are modeled with immediate effect
The mask mandate's effect is linear
Testing capacity increased on Day 30—case detection should rise gradually, not abruptly.
Antiviral stockpiling began on Day 15—mortality reductions would lag by 2 weeks.
The model assumes perfect policy adherence
Curfew timing is off—nighttime mobility data shows 5-day delay in behavioral response.
Vaccine booster campaigns show immediate effect
The 50% work-from-home policy should reduce peak cases by 30%, not the modeled 15%.
The curve underrepresents vaccine efficacy—hospitalizations should decline faster post-Day 60.
Border testing reduced imported variants by 80%, but the graph shows only 20% suppression.
The model overestimates contact tracing's impact—empirical data suggests 40% effectiveness, not 70%.
Air filtration mandates in schools should cut pediatric cases by 25%, which is missing from the curve.
The graph shows full compliance with indoor dining bans
Vaccine passports reduced mobility in unvaccinated groups by 50%, but cases didn't drop proportionally.
The model ignores that mask mandates reduce superspreading events disproportionately (non-linear effect).
The 70% vaccination target was reached, but the curve doesn't show the expected herd immunity threshold.
Stadium closures averted 5K cases/month in prior waves—this isn't reflected in the current projection.
The curve doesn't reflect the new test-to-treat policy initiated last week.
No visible impact from the antiviral rollout—should reduce severe cases by Week 4.
The graph ignores the 30% increase in telework reported in mobility data.
The updated CDC isolation guidelines (5-day rule) aren't incorporated into transmission rates.
The model omits the heatwave effect—outdoor transmission dropped 40% during extreme temperatures.
No adjustment for the new Omicron subvariant's immune evasion despite seroprevalence data.
The curve assumes constant hospitalization rates, but triage protocols changed in high-burden regions.
School winter breaks reduced child cases by 15% historically—this seasonal pattern is missing.
The graph doesn't account for the 20% PCR testing decline due to at-home test underreporting.
Vaccine mandate for healthcare workers should lower nosocomial transmission, but the curve is unchanged.
Hospitalizations are peaking 5 days before cases—this contradicts the typical 7-10 day lag.
The model projects 180-day duration, but wastewater data suggests circulation beyond 240 days.
Deaths are declining while ICU admissions rise—this temporal inversion is implausible.
The second wave starts exactly 90 days post-peak
The epidemic's start date is miscalculated—serology shows community spread 3 weeks earlier.
The curve shows simultaneous peaks across all regions
Testing positivity peaks 2 weeks after case peak—this contradicts lead indicator theory.
The model assumes fixed serial interval
No seasonal ramp-up in cases despite 20% higher indoor mobility during winter months.
The projection shows zero cases by Day 100
The modeled 5% CFR contradicts the 1.2% rate from age-adjusted seroprevalence studies.
The forecast assumes 80% vaccine efficacy against infection
Daily cases are overestimated—wastewater viral load suggests 30% lower community prevalence.
The R0=3.5 assumption ignores that Delta's R0 was 6 in low-masking populations.
Pediatric cases comprise 5% in the model but 15% in ER syndromic surveillance.
The 70% asymptomatic rate is outdated—recent studies show 40% with Omicron sublineages.
Projected deaths are 2x higher than expected given current ventilator inventory limits.
The model uses 2019 population data despite 3% demographic shifts in high-risk age groups.
Reinfection rate is set at 1%/month but is actually 5% for unboosted individuals.
The curve assumes 100% test sensitivity
Peak timing is miscalculated—Google mobility data predicts a 2-week later surge.
The model ignores that prior BA.1 infection delays the BA.5 peak by 6-8 weeks.
The peak arrives during harvest season when migrant worker mobility increases transmission.
Holiday gatherings will accelerate spread—the peak should move 10 days earlier.
The projected peak coincides with school exams when attendance drops 30%—this will flatten it.
Peak is too early given current doubling time of 14 days (should be Day 75, not Day 50).
The curve doesn't account for the 10-day delay from policy announcement to enforcement.
Peak timing assumes uniform vaccination
The model overlooks that heatwaves suppress outdoor transmission, pushing the peak into fall.
The peak aligns with a national holiday—testing artifacts will artificially depress case counts.
Peak hospitalizations exceed ICU bed capacity by 200%—this is unsustainable in reality.
The maximum daily cases (50K) contradicts wastewater-based estimates of 120K viral shedders.
Peak deaths are under-projected given the 40% increase in excess mortality in comparable regions.
The model shows 80% peak test positivity
Peak pediatric cases are 50% lower than school-based surveillance trends suggest.
The curve's peak height assumes constant testing effort, but capacity dropped 30% during surges.
Maximum ventilator use exceeds manufacturing limits by 3x—adjust the severe case estimates.
Peak transmissibility (Rt=4) is biologically implausible given the variant's known R0 of 2.5.
The projected peak ignores that 40% of the population has hybrid immunity from infection+vaccination.
Peak cases align with a testing backlog period—true incidence was likely 20% higher.
The infection curve is too steep
The peak is too narrow—superspreading events would create a wider distribution.
The descent post-peak is too abrupt
The curve assumes homogeneous mixing
Secondary waves are missing
The initial exponential phase is underestimated
The curve is symmetric
Household transmission isn't modeled—expect a steeper initial rise.
The graph ignores seasonality effects, which would modulate the curve.
Asymptomatic cases are omitted, leading to an undercount in early phases.
Susceptible depletion is too rapid
The curve drops to zero, ignoring residual susceptible pockets in populations.
Linear decline is unrealistic
Age-stratified susceptibility isn't reflected—children remain susceptible longer.
The model overestimates cross-immunity from other pathogens.
No accounting for demographic turnover (births/migrations) replenishing susceptibles.
The curve assumes uniform immunity acquisition
Vaccine hesitancy isn't modeled—susceptible pools persist longer.
The decline assumes perfect vaccine efficacy
Behavioral adaptation (e.g., voluntary distancing) slows susceptible depletion unmodeled here.
Recovery rates are overestimated early on
The curve lacks reinfections, causing overestimation of cumulative recoveries.
Plateau occurs too soon
Recovery lag post-infection isn't aligned with empirical hospitalization durations.
The graph ignores partial immunity leading to slower recovery accrual.
No distinction between mild/severe cases—recovery trajectories should bifurcate.
Reinfection waves aren't captured
The curve assumes constant recovery rates
Asymptomatic recoveries are missing, flattening the true curve.
Vaccine-boosted recoveries aren't separated from natural immunity.
The fatality curve is too front-loaded
Long COVID fatalities are omitted, truncating the tail.
The decline assumes perfect healthcare access
Age-specific mortality isn't reflected—older cohorts prolong the tail.
The curve ignores variants with higher lethality causing secondary spikes.
Underreporting isn't factored in
Healthcare collapse during peaks isn't modeled, which would steepen the curve.
The graph lacks seasonal mortality effects (e.g., winter surge in fatalities).
Non-COVID excess deaths (e.g., delayed care) aren't included.
The cumulative curve plateaus too early
School closures' impact appears instantaneously
Vaccine rollout effects are modeled immediately
Travel bans show abrupt efficacy, but imported cases trickle in for weeks.
Lockdown compliance isn't immediate—curve suppression should lag by 14 days.
Mask mandates reduce transmission gradually, not as a step function.
Testing ramp-up effects are delayed
Antiviral stockpiling shows instant benefit, but distribution takes time.
Contact tracing's impact is oversimplified
Quarantine fatigue isn't modeled—effectiveness wanes after 4–6 weeks.
Border controls' effect is overestimated in the first week
Curve suppression from lockdowns is understated—Rt should drop below 0.8.
Vaccine efficacy is overrepresented
The model overestimates mask adherence
Telework policies are ignored—office transmission should decline faster.
Hospital triage protocols aren't reflected
The curve doesn't show the expected dip from holiday gathering bans.
Partial lockdowns are modeled as full
Vaccine inequity isn't captured—regional Rt declines are uneven.
The graph ignores booster campaigns' impact on prolonging immunity.
Curve rebound post-measures is too slow
No visible impact from the new testing policy starting Day 30.
The graph doesn't account for mandated ventilation upgrades in schools.
Vaccine passport implementation is missing from transmission dynamics.
No change in curve after Day 45’s superspreader event restrictions.
The model omits mobile vaccination units deployed in rural areas.
Antiviral rollout from Day 60 isn't reducing severe outcomes.
The curve ignores the 50% work-from-home order effective last week.
No adjustment for variant-specific boosters introduced on Day 75.
Test-to-stay policies in schools aren't affecting case trajectories.
The graph doesn't reflect the nursing home vaccination blitz.
Deaths peak simultaneously with cases
Hospitalizations surge 5 days after cases, but data shows 10–12 day delay.
Immunity waning is modeled at 6 months
The second wave arrives too soon
Vaccination timeline is compressed—doses administered faster than logistics allow.
Case doubling time is 2 days
The epidemic concludes by Day 100
Variant emergence is modeled every 60 days
Testing delays aren't factored in
Seasonal uptick timing is off—should align with winter months, not autumn.
Projected ICU admissions exceed bed capacity by 300%
Case fatality rate is 5%, but population serology suggests 1.2–1.8%.
Vaccine coverage reaches 95% by Day 90
Reinfection rate is 2%
Asymptomatic cases are 20% of total
Rt drops to 0.5 post-lockdown
Pediatric hospitalizations are 10x lower than observed in adjacent regions.
Boosters are modeled for 100% of eligible
Long COVID incidence is 5%
Testing positivity peaks at 15%
Peak occurs on Day 30
Winter surge is missing
The peak is delayed by prior immunity
School reopenings should shift the peak forward by 2 weeks.
Vaccine rollout acceleration moves peak 10 days earlier than projected.
Peak timing aligns with holidays
The curve lacks a bimodal peak from sequential variant waves.
Peak is too late given current Rt<1
Regional hotspots aren't modeled
Behavioral fatigue accelerates peak timing by 1–2 weeks.
Peak caseload is 50,000/day
ICU admissions at peak exceed historical maxima by 200%.
Deaths peak at 1,000/day
Modeled peak prevalence is 15%
Peak hospitalizations assume 100% bed occupancy
Pediatric cases at peak are underestimated by 50%.
Peak transmission occurs in unvaccinated cohorts
Peak wastewater viral load corresponds to higher cases than reported.
The model ignores nursing home outbreaks inflating peak fatalities.
Peak contact tracing efficacy is 80%
